| 1,25 DIHYDROXY VITAMIN D [V0017][MP2] | | 5000 |
| 14-3-3 GAMMA QUANTITATION [AIMS10] | | 12670 |
| 17 ALPHA-HYDROXYPROGESTERONE [ #0028] [MP2] | | 2110 |
| 17 HYDROXY CORTICOSTEROIDS ( KETOGENIC STEROIDS)[#0026][MP6] | | 5100 |
| 17-KETOSTEROIDS[#0029] [MP8] | | 4730 |
| 17-HYDROXY PROGESTERONE (17-OHP) BY CLIA, SERUM(#0028)[MP3] | | 2400 |
| 1P/19Q DELETIONS FISH 6027F [SR7] | | 18640 |
| 1P/19Q DETECTION BY FISH OLIGODENDROGLIMAS TISSUE [MP8] | | 15350 |
| 20Q DELETIONS [LI10] | | 7900 |
| 5-HIAA, URINE 24 HRS(#0006)[MP6] | | 4300 |
| 24 HOUR URINE ALDOSTERONE [A0132][MP2] | | 2820 |
| 24 HOUR URINE CALCIUM[1] | | 610 |
| CATECHOLAMINES, URINE(C0043)[MP9] | | 6000 |
| 24 HOUR URINE CHLORIDE[1] | | 610 |
| 24 HOUR URINE COLLECTION KIT[1] | | 190 |
| 24 HOUR URINE CREATININE[1] | | 660 |
| CITRATE, URINE 24 HRS**(C0117)[MP6] | | 1600 |
| 24 HOUR URINE FOR COPPER[C0154][MP5] | | 2500 |
| 24 HOUR URINE MAGNESIUM [1] | | 870 |
| 24 HOUR URINE METANEPHRINE(M0040)[MP9] | | 4100 |
| 24 HOUR URINE MICROALBUMIN( ALBUMIN) / URINARY CREATININE RATIO(6-4)[M,W,F][2] | | 1500 |
| 24 HOUR URINE MICROALBUMIN(6-4)[M,W,F][2] | | 1220 |
| 24 HOUR URINE PHOSPHORUS[1] | | 690 |
| PORPHOBILINOGEN - QUANTITATIVE , URINE 24 HRS(P0075)[MP8] | | 5000 |
| PORPHYRIA PROFILE, URINE 24 HRS(P0076)[MP8] | | 8200 |
| 24 HOUR URINE POTASSIUM[1] | | 610 |
| 24 HOUR URINE PROTEIN [1] | | 1030 |
| 24 HOUR URINE SODIUM[1] | | 610 |
| 24 HOUR URINE SUPERSATURATION PANEL (CALCIUM, MAGNESIUM,OXALATE,URIC ACID PHOSPHORUS[5002][SR5] | | 2700 |
| 24 HOUR URINE UREA NITROGEN [1] | | 610 |
| 24 HOUR URINE URIC ACID [1] | | 800 |
| VMA (VANILLYL MANDELIC ACID) - QUANTITATIVE, URINE 24 HRS(V0020_LC)[MP6] | | 4400 |
| 409 GENE PANEL[DL10] | | 52730 |
| ABO TITRE [1] | | 750 |
| ABPA MINI ( ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS) [7833][SR3] | | 3230 |
| AABPA PROFILE - ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS(A0629)[MP5] | | 3700 |
| ABPA PROFILE [ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS ] [A0629] [MP3] | | 3610 |
| ABSOLUTE EOSINOPHIL COUNT[1] | | 400 |
| ABSOLUTE NEUTROPHILS COUNT[1] | | 400 |
| ACE - CSF(ANGIOTENSIN CONVERTING ENZYME - CSF) [A0449] [MP5] | | 6320 |
| ACE (ANGIOTENSION CONVERTING ENZYME) [A0448][MP2] | | 1680 |
| ACETYL CHOLINE RECEPTOR ANTIBODIES- ACHR ABS[A0012][MP2] | | 5180 |
| ACID PHOSPHATASE (TOTAL & PROSTATIC FRACRION) PROFILE, SERUM(A0014) | | 1200 |
| ACTH (ADRENO CORTICOTROPIC HORMONE), EDTA PLASMA(A0020)[MP2] | | 2000 |
| APCR (Activated Protein C Resistance), Citrated plasma(A0466)[MP5] | | 5000 |
| ACTIVE MONOMERIC PROLACTIN/ MACROPROLACTIN [P0123][MP3] | | 1390 |
| ACTIVE VITAMIN B12[MP2] | | 1930 |
| ACUTE LEUKEMIA PANEL[UP30] | | 17330 |
| ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) B-CELL/T-CELL BY FISH | | 22520 |
| ACUTE MYELOID LEUKEMIA - AML- PANEL [1047][ SR3] | | 16200 |
| ACUTE MYELOID LEUKEMIA KMT2A (MLL TRANSLOCATION) [LI5] | | 7900 |
| ACUTE PROMYELOCYTIC LEUKEMIA (APL) PML -RARAT(15:27) [LI5] | | 7900 |
| ADAMTS-13[UP5] | | 6400 |
| ADENOSINE DEAMINASE ACTIVITY- ADA[1] | | 1300 |
| ADENOVIRUS PCR [IF3] | | 6220 |
| ADH - ANTI DIURETIC HORMONE (VASOPRESSIN)(8827) [MP8] | | 8020 |
| ADMISSION PACKAGE - STAT - STAT[1] | | 5150 |
| ADRENALINE (EPINEPHRINE), EDTA PLASMA(A0041)[MP9] | | 6200 |
| AEROBIC CULTURE and SENSITIVITY-URINE[3] | | 2100 |
| AFB (ACID FAST BACILLI) SMEAR[1] | | 500 |
| AFB (ACID-FAST-BACILLI) CULTURE BY BACTEC MGIT METHOD[45] | | 1900 |
| AFB DRUG SUSCEPTIBILITY(14DR) BY MGIT- A8455-SIREP-MACC-KE-LZ-LEVOFLOXACIN-BEDAQUILINE[MP28] | | 18700 |
| AFB ISOLATIONBY RAPID CULTURE[MP42] | | 1800 |
| AFB SMEAR FOR MYCOBACTERIUM LEPRAE [1] | | 700 |
| AFB SUSCEPTIBILITY 13 DRUGS(SIRE,PZA,KEPO,MACC) [IF21] | | 17300 |
| AFB SUSCEPTIBILITY 14 DRUGS(IRE,PZA,KEPO,MACC, LZ,MOX2) [HH21] | | 16400 |
| AFB SUSCEPTIBILITY 15 DRUGS(SIRE,PZA,KEPO,MACC, LZ, MOX2) [MP30] | | 18700 |
| AFB SUSCEPTIBILITY 1ST LINE SIRE (STREPTOMYCIN,ISONIAZID,RIFAMPICIN,ETHAMBUTOL) [IF21] | | 6400 |
| AFB SUSCEPTIBILITY 2ND LINE-KEPO(KANAMYCIN,ETHIONAMIDE,PAS,OFLOXACIN) [IF21] | | 4100 |
| AFB SUSCEPTIBILITY 2ND LINE-MACC(MOXIFLOXACIN,AMIKACIN,CAPREOMYCIN,CLOFAZIMINE) | | 4100 |
| AFB SUSCEPTIBILITY SINGLE DRUGS [IF21] | | 2100 |
| AFB TEST BY FLUORESCENCE MICROSCOPY [HH2] | | 800 |
| AFB(TB) ANTIBIOGRAM FOR MTB COMPLEX--MOXIFLOXACIN DRUG BY MGIT- MTB COMPLEX [MP28] | | 3200 |
| AFP (ALPHA FETO PROTEIN) [1] | | 1720 |
| ALANINE AMINOTRANSFERASE (SGPT/ALT)[1] | | 460 |
| ALBERT STAIN C.DIPHTHERIA [1] | | 300 |
| ALBUMIN.[1] | | 300 |
| ALCOHOL (ETHANOL), SERUM[A0129][MP2] | | 3300 |
| ALDOLASE [A0131] [MP5] | | 2190 |
| ALDOSTERONE/RENIN RATIO ALDOSTERONE/PRA RATIO[MP5] | | 10000 |
| ALDOSTERONE-SERUM[A0133][MP2] | | 4820 |
| ALERGEN-INDIVIDUAL DRUGIBUPROFENPAIN KILLER [MP5] | | 1830 |
| ALK1 / EML4 BY FISH [MP12] | | 11490 |
| ALK1 / EML4 BY IHC [PR5] | | 6950 |
| ALKALINE PHOSPHATASE[1] | | 400 |
| FOOD ALLERGEN - ALMOND BADAM(AMYGDALUS COMMUNIS), SERUM(A0180)[MP2] | | 2230 |
| Food Allergen - Brinjal Baingan (Aubergine), Serum(A0185)[MP2] | | 1800 |
| DUST ALLERGEN - DERMATOPHAGOIDES FARINAE (HOUSE DUST MITE), SERUM(A0175)[MP2] | | 2200 |
| ANIMAL ALLERGEN - DOG DANDER, SERUM(A0141)[MP2] | | 2100 |
| ALLERGEN - EXTENDED RHINITIS/ASTHMA SCREENING PANEL [MP3] | | 9320 |
| ALLERGY PANEL - NUTS(A0364)[MP3] | | 6900 |
| Allergy Panel - Grass(A0384) [MP3] | | 7700 |
| ALLERGEN - NON VEG PANEL [1425](SR2] | | 7720 |
| Allergy Panel - Tree Pollen(A0395)[MP3] | | 7000 |
| ALLERGY PANEL - WEED POLLEN(A0396)[MP3] | | 7000 |
| ALLERGEN [ RICE3038-POTATO3107-ONION3211-TOMATO3212-LAMB3332-BEEF3330 ] [SR2] | | 12050 |
| MICRO ORGANISM ALLERGEN - ASPERGILLUS FUMIGATUS (FUNGUS), SERUM(A0316)[MP2] | | 3300 |
| ALLERGEN ASPERGILLUS FUMIGATUS- INHOUSE ALLERGEN [SR2] | | 3000 |
| FOOD ALLERGEN - BAKER'S YEAST (SACCHAROMYCES CEREVISIAE), SERUM(A0186)[MP2] | | 2150 |
| Food Allergen - Banana (Kela/Musa Spp.), Serum(A0187)[MP2] | | 2200 |
| FOOD ALLERGEN - BLUE MUSSEL (MYTILUS EDULIS), SERUM(A0194)[MP2] | | 1870 |
| ANIMAL ALLERGEN - CAT DANDER, SERUM(A0138)[MP2] | | 2200 |
| AFOOD ALLERGEN - CHEDDAR CHEESE, SERUM(A0205)[MP2] | | 2200 |
| FOOD ALLERGEN - CHICKEN MEAT (MURGI), SERUM(A02085)[MP2] | | 2200 |
| MICRO ORGANISM ALLERGEN - CLADOSPORIUM HERBARUM (FUNGUS), SERUM(A0318)[MP2] | | 2200 |
| INSECT ALLERGEN - COCKROACH (GERMAN - BLATELLA GERMANICA), SERUM(A0311)[MP2] | | 2200 |
| ALLERGEN COCOA - CHOCOLATE (THEOBROMA CACAO)[MP2] | | 1850 |
| ALLERGY PANEL - ADULT COMPREHENSIVE PANEL(A0372)[MP3] | | 19300 |
| ALLERGEN COMPREHENSIVE PANEL INFANCY (< 5 YEARS) (1408) [SR3] | | 16200 |
| DUST ALLERGEN - DERMATOPHAGOIDES PTERONYSSINUS (HOUSE DUST MITE), SERUM(A0176)[MP2] | | 2200 |
| ALLERGEN ECZEMA / GIT (NON VEG and VEG) PANEL (3376) [SR3] | | 14660 |
| ALLERGY PANEL - ECZEMA COMPREHENSIVE (VEG)(E0065)[MP3] | | 7100 |
| FOOD ALLERGEN - EGG WHITE (ANDA), SERUM(A0224)[MP2] | | 2200 |
| FOOD ALLERGEN - EGG YOLK (ANDA), SERUM(A0225)[MP2] | | 2200 |
| ALLERGEN EXTENDED RHINITIS ASTHMA PANEL-ADULT [3405] [SR3] | | 16200 |
| ALLERGEN EXTENDED RHINITIS-ASTHMA PANEL-CHILD [3404] [SR3] | | 16200 |
| ALLERGEN FOOD PANEL- FRUITS-1 [4081][SR2] | | 6460 |
| ALLERGEN FOOD PANEL- FRUITS-2 [4087][SR2] | | 5230 |
| FOOD ALLERGEN - LENTIL (MASOOR DAL - LENS ESCULENTA), SERUM(A0243)[MP2] | | 1900 |
| ALLERGEN FOOD PANEL VEG [1414][SR3] | | 7710 |
| ALLERGEN FOOD PANEL- VEG-2 [4083][SR2] | | 7710 |
| ALLERGEN FOOD PANEL- VEGETABLES [4086][SR2] | | 6930 |
| ALLERGEN FOOD PANEL3 (3074) [SR3] | | 6170 |
| ALLERGEN -FOOD PANEL-PULSES [4091][SR3] | | 6170 |
| FOOD ALLERGEN - GLUTEN, SERUM(A0230)[MP2] | | 2100 |
| ALLERGEN INDIVIDUAL DRUG - RIFAMPICIN [MP7] | | 2160 |
| ALLERGEN INDOOR PANEL (1428) [SR2] | | 8870 |
| ALLERGEN LAMB MUTTON (3332)[SR2] | | 2150 |
| ALLERGEN LATEX [MP2] | | 2160 |
| ALLERGEN LIDOCAINE [MP6] | | 2350 |
| ALLERGEN MANGO [3054] [SR3] | | 2120 |
| ALLERGEN MILK [COW MILK - DOODH] [MP2] | | 1720 |
| ALLERGEN MOLD PANEL [3034] [SR2] | | 6170 |
| ALLERGEN PEANUTS (3077) [SR3] | | 2160 |
| ALLERGEN PENICILLUM (PENICILLIN G 3195 + PENICILLIN V 3188) [SR2] | | 4330 |
| ALLERGEN -PHADIATOP SINGLE ALLERGEN(4430)[SR2] | | 2150 |
| ALLERGEN RHINITIS/ASTHMA (3377) [SR2] | | 7140 |
| ALLERGEN -RICE [3038][SR2] | | 2160 |
| ALLERGEN SCREEN ADULT [8239] [SR2] | | 1720 |
| Food Allergen - Soybean (Glycine Max), Serum(A0282)[MP2] | | 2000 |
| FOOD ALLERGEN - WALNUT (JUGLANS CALIFORNICA), SERUM(A00292)[MP2] | | 2000 |
| FOOD ALLERGEN - WHEAT (GEHON - TRITICUM AESTIVUM), SERUM(A0294)[MP2] | | 2200 |
| ALLERGEN-FOOD MIX FX7(TOMATO,YEAST,GARLIC,ONION,CELERY)[4187][SR2] | | 2400 |
| ALLERGY – ENVIRONMENTAL PANEL (A0382)[MP3] | | 19370 |
| ALLERGY -ADULT PANEL - 3[A0636][MP3] | | 10760 |
| ALLERGY DRUG PANEL - (COMPREHENSIVE - 35 DRUG) [MP5] | | 19060 |
| ALLERGY PANEL - DUST(A0379)[MP3] | | 5300 |
| ALLERGY PANEL ASTHMA/ RHINITIS COMPREHENSIVE WITH MONITORING 4[MP3] | | 24450 |
| ALLERGY - FLEXI PANEL (ANY 10 ALLERGENS)(A0571)[MP6] | | 9500 |
| ALLERGY - FLEXI PANEL (ANY 5 ALLERGENS)(A0576)[MP6] | | 5400 |
| ALLERGY PANEL FOOD FRUIT[MP4] | | 7850 |
| ALLERGY PANEL-OTHERS DRUG PANEL( MAXI 12 PARAMETERS A0377) [MP7] | | 14040 |
| ALLERGY SCREENING PHADIATOP [MP2] | | 2160 |
| ALLERGY SCREENING TRYPTASE [MP6] | | 2870 |
| ALLERGY TEST FOR HLAB1502[HH4] | | 5460 |
| ALPHA THALASSEMIA BY PCR[MP7] | | 7900 |
| ALPHA THALASSEMIA MOLECULAR STUDIES[MP10] | | 22960 |
| ALPHA 1 ANTITRYPSIN, SERUM(A0404)[MP2] | | 4500 |
| ALPHA-2-MACROGLOBULIN [MP3] | | 4640 |
| ALPS SCREENING [SL3] | | 8490 |
| CHROMOSOMAL MICROARRAY - 315K / LOW RESOLUTION[LI15] | | 25800 |
| CHROMOSOMAL MICROARRAY 750K / HIGH RESOLUTION[LI15] | | 28600 |
| ALUMINIUM LEVEL BLOOD [A0414][MP8] | | 4330 |
| Alzheimer Disease Screening Profile, CSF (A0623)[MP9] | | 19280 |
| ALZHEIMER’S GENETIC TESTING [DL31] | | 23150 |
| AMA OR TPO (ANTI THYROID MICROSOMAL ANTIBODY / ANTI THYROID PEROXIDASE - TPO)[M,W,F][2] | | 2400 |
| AML COMBI PANEL ( KARYOTYPING , FISH, MOLECULAR MARKERS NPM-CEBPA, FLT3) [LI10] | | 42300 |
| AML WITH NORMAL CYTOGENETICS (FLT3, NPM1, CEBPA) [9303] [SR12] | | 13100 |
| AMMONIA. [1] | | 1030 |
| AMOEBIASIS IGG ANTIBODIES [MP4] | | 1870 |
| AMPHIPHYSIN ANTIBODY A0430 [MP7] | | 6450 |
| AMYLASE CREATININE CLEARANCE RATIO (ACCR)[1] | | 1650 |
| AMYLASE.[1] | | 680 |
| AMYLOID A[MP8] | | 5740 |
| ANA BY IMMUNOBLOT -17 ANTIGENS [MP2] | | 5410 |
| ANA ELISA METHOD [A0436][MP2] | | 1140 |
| ANA -IMMUNOFLUORESCENCE [MP2] | | 1850 |
| ANA POSITIVE REFLEX TO EIA PROFILE (DSDNA WITH TITRES,SS-U1-SNRNP,SMITH ABS)[ 9206RFX][SR5] | | 4900 |
| ANA (Anti-Nuclear Antibody)PROFILE(A0438)[MP4] | | 7200 |
| ANAEROBIC CULTURE [7] | | 1900 |
| ANCA POSITIVE REFLEX MPO, PR3 ANTIBODIES[MP2] | | 3800 |
| ANDROSTENEDIONE, SERUM(A0447)[MP3] | | 2600 |
| ANNUAL ICU SURVEILLANCE TESTING PROGRAMME-4 VISITS(1/QUARTER) | | 17400 |
| ANNUAL OT SURVEILLANCE TESTING PROGRAMME-12 VISIT | | 27900 |
| ANTI X-A FACTOR ASSAY [HH2] | | 7670 |
| ANTI AQUAPORIN 4 [ NMO ANTIBODIES] ANTI NEUROMYELETIS OPTICA[MP4] | | 7310 |
| ANTI CARDIOLIPIN IGG [PR2] | | 1080 |
| ANTI CARDIOLIPIN IGM [PR2] | | 1080 |
| Desmoglein I Antibody (Vesiculobullous disorders), Serum(D0009)[MP6] | | 4700 |
| Desmoglein III Antibody (Vesiculobullous disorders), Serum (D0010)[MP6] | | 4700 |
| ANTI DNASE B [MP4] | | 3700 |
| ANTI DS DNA[D0032][MP2] | | 1900 |
| ANTI GLIADIN IGA ANTIBODIES [MP5] | | 3210 |
| ANTI GLIADIN IGG ANTIBODIES [MP5] | | 3210 |
| ANTI HAV (HEPATITIS A VIRUS) IGM[1] | | 1340 |
| ANTI HAV IGG [MP2] | | 2020 |
| ANTI HBCAG - TOTAL ANTIBODIES TO HEPATITIS B CORE ANTIGEN [MP2] | | 1610 |
| ANTI HBSAG - TOTAL ANTIBODIES TO HEPATITIS B SURFACE ANTIGEN [M,W,F][2] | | 500 |
| ANTI HDV - TOTAL (TOTAL ANTIBODIES TO HEPATITIS DELTA VIRUS) [MP5] | | 3180 |
| ANTI HEPATITIS E VIRUS IGG [H0079 ] [MP4] | | 2330 |
| ANTI HEV (HEPATITIS E VIRUS) IGM[1] | | 1650 |
| ANTI INSULIN ANTIBODY [PK9] | | 4330 |
| ANTI MOG ( MYELIN OLIGODENDROCYTE GLYCOPROTEIN ) ANTIBODIES(MP6) | | 10030 |
| ANTI MULLERIAN HORMONE ,SERUM[1] | | 3930 |
| ANTI NF-140 FOR CIDP [AM7] | | 5740 |
| OVARIAN ANTIBODY, SERUM(O0020)[MP8] | | 5100 |
| ANTI OVARIAN ANTIBODIES TITRES (1180T) [SR5] | | 8640 |
| APA PHOSPHOLIPID - IGG ANTIBODY, SERUM(A0464)[MP4] | | 1800 |
| APA PHOSPHOLIPID - IGM ANTIBODY, SERUM(A0465)[MP4] | | 1800 |
| ANTI PHOSPHOLIPID SYNDROME PACKAGE(P0052)[MP5] | | 4700 |
| ANTI PLATELET ANTIBODY[MP8] | | 9260 |
| SPERM ANTIBODY TOTAL, SERUM(S0040)[MP5] | | 2200 |
| ANTI STREPTOLYSIN O ( ASO)[1] | | 580 |
| ANTI THYROGLOBULIN ANTIBODY(ATG)[M,W,F][2] | | 1400 |
| ANTI THROMBIN III ACTIVITY FUNCTIONAL, CITRATED PLASMA(A0458)[MP5] | | 8500 |
| APOLIPOPROTEIN A1 and B [M,W,F 2] | | 1000 |
| APTT (ACTIVATED PARTIAL THROMBOPLASTIN TIME)[1] | | 700 |
| BETHESDA ASSAY (Quantitative Factor Inhibitor)(B0031)[UP4] | | 7700 |
| ARSENIC LEVEL - WHOLE BLOOD [9141] [MP6] | | 6290 |
| ASCA - IGA ANTIBODY, SERUM(A0480)[MP5] | | 4300 |
| ASCA - IgG antibody, Serum(A0481)[MP5] | | 4300 |
| ASCITIC/PERITONEAL FLUID ROUTINE EXAMINATION[1] | | 2590 |
| ASCORBIC ACID ( VITAMIN C )(3516) [MP9] | | 5190 |
| ASKA SKELETAL (STRIATED) MUSCLE ANTIBODY [MP4] | | 4880 |
| ASMA- ANTI SMOOTH MUSCLE ANTIBODIES [MP3] | | 3860 |
| ASPARTATE AMINOTRANSFERASE (SGOT /AST)[1] | | 390 |
| ASPERGILLOSIS IGG ANTIBODIES [MP5] | | 3000 |
| ASPERGILLUS SPECIFIC IGE [MP2] | | 2160 |
| ASPERGILLUS SPECIFIC IGM [MP8] | | 3000 |
| ATYPICAL PNEUMONIA /RESPIRATORY TRACT INFECTION PROFILE IGM[MP9] | | 9850 |
| ATYPICAL PNEUMONIA MULTIPLEX [IF2] | | 8610 |
| Autoimmune Encephalitis Profile-2 DPPX (A0617-Serum)[MP9] | | 40980 |
| Autoimmune Encephalitis Profile(A0617-CSF)[MP9}) | | 30800 |
| Autoimmune Encephalitis Profile 1 (A0497 – Serum) [MP3] | | 29800 |
| AUTOIMMUNE LIVER DISEASE PROFILE [MP5] | | 6330 |
| AUTOMATED FLUID CULTURE BY BACT ALERT SYSTEM[1] | | 1900 |
| BACTERIA FUNGAL CNS PANEL [IG4] | | 24070 |
| BACTERIAL ANTIGEN DETECTION ( 5 ORGANISMS) CSF/URINE/SERUM[MP2] | | 6030 |
| BACTERIAL PNEUMONIA MULTIPLEX PANEL [IF3] | | 28700 |
| BACTERIAL SEPSIS MULTIPLEX [IF2] | | 24830 |
| BARBITURATES (BLOOD) [BH5] | | 900 |
| FISH FOR LYMPHOMA B-CELL (FFPE BLOCK)[LI8] | | 25200 |
| BCR ABL1 FISH FOR CML CHRONIC PHASE CP[LI5] | | 7900 |
| RT-QPCR FOR BCR-ABL1 TRANSCRIPTCOPIES P210(IS), QUANTITATIVE[LI5] | | 10500 |
| BETA 2 TRANSFERRIN [HH3] | | 8890 |
| BETA 2 GLYCOPROTEIN I IGG (PHOSPHOLIPID) [MP5] | | 2470 |
| BETA 2 GLYCOPROTEIN I IGM (PHOSPHOLIPID) [MP5] | | 2470 |
| BETA-2 MICROGLOBULIN, SERUM(B0031)[MP2] | | 2200 |
| BETA-2 CROSSLAPS CTX-1, EDTA PLASMA(B0026)[MP4] | | 3200 |
| BETA THALASSEMIA MUTATION [LI15] | | 7900 |
| BETA THALASSEMIA MUTATION ANALYSIS [ 5 COMMON MUTATIONS] [MP11] | | 8610 |
| BETA TRACE PROTEIN [HH3] | | 8610 |
| BETA-THALASSAMIA, BETA GLOBIN (HBB) GENE SEQUENCING [MP10] | | 11200 |
| B-HCG (BETA HUMAN CHORIONIC GONADOTROPIN)[1] | | 1100 |
| BICARBONATE[1] | | 450 |
| BILE ACIDS-TOTAL[MP2] | | 2600 |
| BILIRUBIN[1] | | 480 |
| BILIRUBIN BY CAPILLARY METHOD [1] | | 580 |
| BIOFIRE FILMARRAY - RESPIRATORY PANEL R0066[MP3] | | 24110 |
| BIOFIRE FILMARRAY-PNEUMONIA PANEL-LOWER RESPIRATORY TRACT[ B0108][MP3] | | 37300 |
| BIOPSY / TISSUE IMMUNOFLUORESCENT [1527][SR5] | | 6260 |
| BIOPSY WITH IMMUNOHISTOCHEMISTRY [SR7] | | 9260 |
| BIOTINIDASE LEVEL- NEONATAL [LL8] | | 6260 |
| BISMUTH ICPMS , BLOOD [MP15] | | 4300 |
| BK VIRUS DNA DETECTION PCR [MP7] | | 7900 |
| BK VIRUS QUANTITATIVE REAL TIME PCR[RLS5] | | 7050 |
| BK VIRUS URINE BY RT PCR [MP7] | | 7900 |
| BLEEDING and CLOTTING TIME ( BT CT) [1] | | 300 |
| BLOOD CULTURE - AEROBIC ( BAC T ALERT SYSTEM)[2,6] | | 2300 |
| BLOOD CULTURE- ANAEROBIC ( BAC T ALERT SYSTEM)[8] | | 2000 |
| BLOOD GAS ANALYSIS -ARTERIAL-COMPREHENSIVE PANEL[1] | | 2510 |
| BLOOD GAS ANALYSIS CAPILLARY METHOD [1] | | 910 |
| BLOOD GAS ANALYSIS -VENOUS[1] | | 1900 |
| BLOOD GROUP and RH FACTOR [1] | | 350 |
| BLOOD SUGAR FASTING FBS ( FASTING PLASMA GLUCOSE FPG)[1] | | 220 |
| BLOOD SUGAR POSTPRANDIAL - PPBS ( BLOOD GLUCOSE PLASMA PRANDIAL[1] | | 220 |
| BLOOD SUGAR RANDOM (RBS) / BLOOD GLUCOSE RANDOM[1] | | 220 |
| BLOOD UREA NITROGEN ( BUN )[1] | | 350 |
| BODY FLUID - EOSINOPHILLS [1] | | 300 |
| BONE MARROW ADVANCE [BIOPSY+ ASPIRATE] INTERPRETATION [SL7] | | 9930 |
| BONE MARROW ASPIRATION AND BIOPSY SECOND OPINION [SL4] | | 10800 |
| BONE MARROW ASPIRATION AND IRON STAIN [HH4] | | 1080 |
| BONE MARROW BIOPSY INTERPRETATION [7] | | 1870 |
| BONE MARROW FOR CONVENTIONAL KARYOTYPING [LI10] | | 6840 |
| BONE MARROW FOR MYD 88( L265P) [LI6] | | 9040 |
| BONE MARROW SMEAR EXAMINATION [2] | | 1870 |
| BONE MARROW STAINING OR HISTOPATH SLIDE PREPARATION ONLY () [1] | | 270 |
| BPD ENZYME PHENOTYPE GENETIC TESTING [DL18] | | 11670 |
| BRAF (MB14) [AC12] | | 7820 |
| BREAST AND OVARIAN CANCER PANEL (GERMLINE CANCER) TEST) 20 GENE INCLUDING BRCA1 and BRCA2 [SL21] | | 18000 |
| Brucella - IgG antibody, Serum(B0064)[MP4] | | 1700 |
| Brucella - IgM antibody, Serum(B0065)[MP4] | | 1700 |
| BULLOUS PEMPHIGOID 180 B0066[MP15] | | 5570 |
| BULLOUS PEMPHIGOID [MP15]230 B0067 | | 5570 |
| BUN/CREATININE RATIO [1] | | 910 |
| C PEPTIDE - FASTING [MP2] | | 1680 |
| C PEPTIDE - POST PRANDIAL [MP2] | | 1750 |
| C1 ESTERASE INHIBITOR [MP4] | | 4460 |
| C5 - COMPLEMENT FRACTION[MP35] | | 10050 |
| CA - 72-4 (CANCER ANTIGEN 72-4) [LL4] | | 2860 |
| CA -15.3 (CANCER ANTIGEN 15.3) | | 1000 |
| CA -15-3 (CANCER ANTIGEN -15-3) [MWF][2] | | 1850 |
| CA -19.9 (CANCER ANTIGEN 19.9)[1] | | 2000 |
| CA-125 (CANCER ANTIGEN 125)[M,W,F][2] | | 1900 |
| CALCITONIN THYROCALCITONIN, SERUM(C0014)[MP2] | | 3600 |
| CALCIUM[1] | | 480 |
| CALRETICULIN MUTATION ASSAY -EX 9 [GG9] | | 13630 |
| CULTURE & IDENTIFICATION - CAMPYLOBACTER, STOOL(S0083)[MP6] | | 3300 |
| C-ANCA (ANCA-CYTOPLASM)(P0081)[MP3] | | 1800 |
| CANCER MARKER SCREEN -ONCOSURE 13 [4209] [SR8] | | 7410 |
| CANDIDA ALBICANS ANTIBODIES [MP] | | 6490 |
| CANDIDA SPECIES BY PCR [IG2] | | 4300 |
| Carbamazepine Tegretol, Serum(C0032)[MP2] | | 1400 |
| CARBAMAZEPINE 10.11 EPOXIDE -SERUM [80682] [SR23] | | 22280 |
| CARBAPENEM RESISTANCE DETECTION BY RAPID METHOD[1] | | 3100 |
| CARBAPENEM RESISTANCE DETECTION BY GENEXPERT[1] | | 7600 |
| CARDIAC CHANNELOPATHY GENE PANEL[MGM001][MG32] | | 51680 |
| CARDIOLIPIN - IGA ANTIBODY, SERUM(C0037)[MP4] | | 1400 |
| CARDIOVASCULAR PHARMACOGENETIC DRUG PANEL[DL17] | | 27010 |
| CARIS ( MOLECULAR INTELLIGENCE PROFILE ) [OD40] | | 724610 |
| CARNITINE [NG3] | | 6170 |
| CATECHOLAMINES, EDTA PLASMA(C0042)[MP7] | | 10000 |
| CCP - ANTIBODIES TO CYCLIC CITRULLINATED PEPTIDE[M,W,F][2] | | 2800 |
| CD 19 [MP2] | | 3580 |
| CD20 ( PAN-B CELL ) -PHOTO [Z022K] [SR4] | | 4160 |
| CD20[C0064][MP3] | | 3400 |
| CD3 / CD4, CD8 - ABSOLUTE COUNT [MP3] | | 2700 |
| CD34 COUNT[SL1] | | 9730 |
| CD4 and CD8 DETERMINATION[MP2] | | 6200 |
| CD4 ( LYMPHOCYTE SUBSET PERCENTAGE AND ABSOLUTE COUNT) [1659] SR2] | | 7720 |
| CD4 COUNT LYMPHOCYTE ENUMERATION STUDY - T CELLS (1656B) [SR2] | | 2330 |
| CEA (CARCINO EMBRYONIC ANTIGEN)[1] | | 1220 |
| CELIAC PROFILE | | 5460 |
| CENTROMERE ANTIBODIES [MP5] | | 2860 |
| CERULOPLASMIN (COPPER OXIDASE ) [MP2] | | 1930 |
| CHIKUNGUNYA IGM ANTIBODIES[1] | | 1790 |
| Chikungunya RNA Detection by RT-PCR, Serum(C0369)[MP2] | | 4970 |
| CHIMERISM ANALYSIS -POST[{RECEPIENT}TH10] | | 7090 |
| CHIMERISM STR ANALYSIS -PRE{DONOR OR RECIPIENT} [TH10] | | 19250 |
| CHLAMYDIA TRACHOMATIS DNA DETECTION BY RT-PCR, URINE(C0093)[MP6] | | 5700 |
| CHLAMYDIA PNEUMONIAE -IGM C0097[MP10] | | 2650 |
| CHLAMYDIA TRACHOMATIS IGA[MP4] | | 1300 |
| CHLAMYDIA TRACHOMATIS IGG[MP4] | | 1400 |
| CHLAMYDIA TRACHOMATIS IGM [MP4] | | 1850 |
| CHLORIDE[1] | | 350 |
| Pseudo Cholinesterase OPC poisoning, Serum(P0113)[MP2] | | 1700 |
| CHROMAGRANIN A [MP2] | | 8610 |
| CHROMIUM, BLOOD [C0107]MP6] | | 3500 |
| CHROMOSOMAL BREAKAGE STUDY [LI10] | | 13670 |
| CHROMOSOMAL MICROARRAY - AFFYMETRIX CYTOSCAN and CLINICAL EXOME BY NGS + CGS [MG28] | | 64560 |
| CHROMOSOMAL MICROARRAY ASSAYS (ALTUM 315K) (POC/PLACENTA) [LI15] | | 11800 |
| CHROMOSOME ANALYSIS IN HEMATOLOGICAL DISORDERS [5800] [SR15] | | 8470 |
| CHRONIC LYMPHOPROLIFERATIVE DISORDER PANEL - IMMUNOPHENOTYPING [SL2] | | 20060 |
| CHRONIC PROGRESSIVE EXTERNAL OPTHALMOPLEGIA - CPEO [MP7] | | 10330 |
| CHYLOMICRONS QUALITATIVE-BODY FLUIDS[C0318][MP2] | | 850 |
| CIC - IGM ANTIBODIES TO CIRCULATING IMMUNE COMPLEX. [MP18] | | 5840 |
| CLINICAL EXOM PANEL[MG25] | | 28600 |
| CLINICAL EXOME 2 GENES NOTCH 3 and APOE [SL35] | | 46270 |
| CLINICAL EXOME 20MB - (80-100X) [SL42] | | 52440 |
| ONCOINSIGHTS CLINICAL EXOME SEQUENCING[LI50] | | 26300 |
| CLINICAL EXOME SEQUENCING[30] | | 30800 |
| CLL PANEL BY FISH (13Q14.3, 17P13.1,11Q22.3 DELETIONS AND TRISOMY 12)[ 6024F][SR9] | | 10600 |
| CLOSTRIDIUM DIFFICILE PCR [MP7] | | 5100 |
| CLOSTRIDIUM DIFFICILE TOXIN A-B[1] | | 5690 |
| CLOT RETRACTION TIME [1] | | 200 |
| CMV (CYTOMEGALO VIRUS) IGG [MP2] | | 1140 |
| CMV (CYTOMEGALO VIRUS) IGM [MP2] | | 1140 |
| CMV (CYTOMEGALOVIRUS) AVIDITY, SERUM(C0182)[MP8] | | 1600 |
| CMV DNA BY NESTED DNA PCR [RLS3] | | 3610 |
| CMV DNA DETECTION BY RTPCR -TISSUE [MP5] | | 6270 |
| CMV DNA VIRAL LOAD (DNA QUANTITATIVE) -TISSUE[HH6] | | 7950 |
| CMV DNA VIRAL LOAD TISSUE (DNA QUANTIFICATION)- TISSUE [RLS4] | | 12850 |
| CMV IGG ANTIBODIES FROM CSF [MP5] | | 3570 |
| CMV (CYTOMEGALOVIRUS) DNA QUANTITATIVE (VIRAL LOAD), EDTA PLASMA(C0143)[MP4] | | 11500 |
| CMV (CYTOMEGALOVIRUS) DNA DETECTION BY RT-PCR, CSF(C0134)[MP4] | | 7700 |
| CN1A ANTIBODY [TTSH10] | | 18660 |
| COBALT, BLOOD [MP7] | | 5400 |
| CODE SENSITITRE MIC FOR FUNGAL SUSCEPTIBILITY(MOLD) [HH5] | | 5200 |
| CODE SENSITITRE MIC -FUNGAL SUSCEPTIBILITY(CRYPTOCOCCUS) [HH5] | | 1600 |
| COENZYME Q10-COQ10, SERUM[C1047][MP15] | | 29000 |
| CCOLD AGGLUTININ, SERUM(C0149([MP3] | | 1200 |
| COLORECTAL CANCER PANEL (KRAS,NRAS and BRAF)[ 4550][SR12] | | 17700 |
| COMBO-EXOMEMIT-WHOLE EXOME and MITOCHONDRIAL GENOME SEQUENCING(MGM1722)[MG25] | | 43470 |
| COMMUNITY ACQUIRED PNEUMONIA PANEL [IG3] | | 37020 |
| COMPLEMENT 3 (C3) [MP2] | | 920 |
| COMPLEMENT 4 (C4) [MP2] | | 920 |
| COMPLEMENT TOTAL CH-50 [MP8] | | 5410 |
| COMPLETE BLOOD COUNT- CBC-OPD[1] | | 500 |
| COMPLETE BLOOD COUNT (CBC) WITH PLATELET COUNT BY MANUAL METHOD[1] | | 610 |
| COMPLETE BLOOD COUNT- CBC[1] | | 500 |
| COMPLETE BLOOD COUNT WITH ESR (CBC ESR)[1] | | 720 |
| COMPLETE BLOOD COUNT WITH PERIPHERAL SMEAR STUDY (CBC PS)[1] | | 800 |
| COMPLETE HEALTH CHECK PACKAGE OUT REACH CENTRE[3] | | 8070 |
| COMPLETE PNEUMONIA MULTIPLEX (34 TARGETS)[[IF2] | | 19870 |
| COMPLEX PNEUMONIA MULTIPLEX (34 TARGETS)[[IF2] | | 22960 |
| COMPREHENSIVE BETA THALASSEMIA -HBB GENE ANALYSIS [MG15] | | 20090 |
| COMPREHENSIVE CARDIAC GENETIC SCREEN PANEL [DL30] | | 76370 |
| COMPREHENSIVE GENOMIC PROFICIENCY ON TUMOR BLOCK[32] | | 149000 |
| COMPREHENSIVE HEREDITARY CANCER GENE PANEL(TEST CODE : MGM1841)[MG30] | | 28600 |
| CONTINUOUS GLUCOSE MONITORING (CGM) (AMBULATORY GLUCOSE PROFILE – AGP) [14+1] | | 5300 |
| COOMBS TEST-DIRECT (DCT) [1] | | 690 |
| COOMBS TEST-INDIRECT (ICT) [1] | | 870 |
| COPPER SERUM [MP5] | | 3000 |
| CORTISOL -4PM-6PM | | 1470 |
| CORTISOL -8AM-10AM | | 1470 |
| CORTISOL -RANDOM | | 1470 |
| COVID NEUTRALISING ANTIBODY TEST[BC4] | | 7180 |
| COVID-19 ANTIBODY DONOR SCREENING ONE UNIT [1] | | 3050 |
| COVID19 ANTIBODY DONOR SCREENING TWO UNIT [1] | | 4560 |
| COVID-19 ANTIBODY DOSE 1- AFTER 4-6 WEEKS[1] | | 10 |
| COVID-19 ANTIBODY DOSE 2- AFTER 4-6 WEEKS[1] | | 10 |
| COVID-19 ANTIGEN (AG) TEST [1] | | 290 |
| COVID-19 ANTIGEN TEST BY CLIA METHOD [1] | | 290 |
| COVID19 DETECTION BY RTPCR (SARS COV2( [1920] [IF/SR3] | | 860 |
| COXSACKIE IGG ANTIBODY (MP8)[C0161] | | 3290 |
| COXSACKIE IGM ANTIBODY ([C0162][MP8] | | 3290 |
| CPK / CK[1] | | 700 |
| CPK MM / CK MM [HH2] | | 2150 |
| CPK-MB / CKMB[1] | | 970 |
| CREATININE[1] | | 440 |
| CREATININE CLEARANCE TEST (CCT) [1] | | 680 |
| CREATININE FOR CARDIAC-CT[1] | | 780 |
| CRP (C-REACTIVE PROTEIN)[1] | | 910 |
| CRYOGLOBULINS (QUALITATIVE) [MP3] | | 1480 |
| CRYPTOCOCCUS ANTIGEN [1] | | 2280 |
| CRYPTOCOCCUS NEOFORMANS DNA DETECTION BY PCR [MP11] | | 12200 |
| CSF AFP (ALPHA FETO PROTEIN) [A0121][MP2] | | 1300 |
| CSF AMINO ACIDS -QUANTITATIVE [MP16] | | 12500 |
| CSF CELL BLOCK WITH IHC AND CYTOLOGY [HH9] | | 16500 |
| CSF DENGUE RNA DETECTION BY REAL TIME PCR [D0007] [MP4] | | 5170 |
| CSF FOR I4.3.3 PROTEIN [82528][SR18] | | 16970 |
| CSF FOR LACTATE[L0001] [MP2] | | 1350 |
| CSF IGA [PR2] | | 1390 |
| CSF IGG [PR2] | | 1390 |
| CSF IGM [MP5] | | 1810 |
| CSF INDEX [C0181][MP3] | | 3600 |
| CSF ROUTINE EXAMINATION | | 1720 |
| CSF THYROID ANTIBODIES ( ATAB TPO AND ATA) [T0060][MP2] | | 2850 |
| CSF VARICELLA (HERPES) ZOSTER - IGG ANTIBODIES [MP5 ] | | 4840 |
| CSF WET MOUNT FOR ORGANISM IDENTIFICATION[HH2] | | 1140 |
| CULTURE AND INDETIFICATION BY MALDI TOFF (AEROBIC BACTERIA) [MP3] | | 1800 |
| CULTURE AND SENSITIVITY FOR AEROBIC BACTERIA [MP3] | | 1800 |
| CYCLOSPORINE A -C-2-LEVEL[HH2] | | 6450 |
| CYCLOSPORINE A -CO-LEVEL[HH2] | | 6450 |
| CYFRA (CA) 21-1[C0212] [MP4] | | 4480 |
| CYP21A2 MLPA [LI21] | | 22350 |
| CYP2C9 (12,3) VKORC1(163G>A) GENOTYPING [LI22] | | 11600 |
| CYSTATIN C [C0214] [MP2] | | 1940 |
| CYSTIC FIBROSIS DELTA F508 MUTATION [NG16] | | 5370 |
| CYSTIC FIBROSIS FIVE COMMON MUTATIONS- DELTA, F508, 621+G-T, G542X, R553D, G551X, AND G542X) [ NG16] | | 8900 |
| CYSTICERCUS - IGG ANTIBODIES [MP5] | | 2770 |
| CYTOCHEMISTRY PANEL(C0224)[MP6] | | 4500 |
| CYTOGENETICS : DEL 13Q [LI5] | | 7960 |
| CHROMOSOMAL BREAKAGE ANAYLSIS - FANCONIS ANEMIA, HEPARIN BLOOD**(C0113)[MP22] | | 10100 |
| CYTOLOGY - EBUS TBNA [2] | | 1980 |
| CYTOLOGY SECOND OPINION [PR6] | | 11550 |
| CYTOLOGY 2ND OPINION[4] | | 1900 |
| CYTOLOGY EXAMINATION > 5 SLIDES[2] | | 2110 |
| CYTOLOGY EXAMINATION[2] | | 1300 |
| CYTOLOGY EXAMINATION [SR5] | | 4910 |
| CYTOLOGY FOR WBC COUNTS[2] | | 1070 |
| CYTOMEGALOVIRUS (CMV),QUALITATIVE RT PCR [IF3] | | 5740 |
| D DIMER ASSAY[1] | | 2430 |
| D3 HYDROXYBUTYRATE -KETONE BODY(D0050) [MP2] | | 1370 |
| DCP-DECARBOXY PROTHROMBIN PIVKA-II | | 4400 |
| DELTA AMINOLEVULINIC ACID(QUANTITATIVE) [NG7] | | 7390 |
| Dengue - IgG antibody(D0003)[MP2] | | 760 |
| DENGUE IGM BY ELFA[1] | | 860 |
| DENGUE RNA DETECTION BY REAL TIME PCR PLASMA [D0008][MP4] | | 5170 |
| DENGUE-NS1 ANTIGEN DETECTION BY ELFA[1] | | 860 |
| DEROMATOLOGY GFC1 PRP LAB PROCESSING *1 [1] | | 500 |
| DEROMATOLOGY GFC3 PRP LAB PROCESSING *3 [1] | | 1490 |
| DEROMATOLOGY GFC4 PRP LAB PROCESSING *4[1] | | 2000 |
| DEROMATOLOGY GFC6 PRP LAB PROCESSING *6 [1] | | 2980 |
| DETECTION OF BRAF V600E MUTATIONS [LI7] | | 9040 |
| DEXAMETHASONE SUPPRESSION TEST FOR CORTISO-LOW DOSE [MP2] | | 1620 |
| DHEA (Dehydroepiandrostenedione), Serum(D0017)[MP5] | | 3740 |
| DHEAS (DIHYDROEPIANDROSTENEDIONE SULPHATE) [MP2][D0018] | | 1680 |
| DHT (DI HYDRO TESTOSTERONE), SERUM(D0019)[MP3] | | 4600 |
| DIALYSIS FLUID ELECTROLYTES[1] | | 870 |
| DICLOFENAC PAIN KILLER[A8606] [MP5] | | 1680 |
| DIGOXIN [MP2][D0024] | | 1350 |
| DIHYDROPYRIMIDINE DYHYDROGENASE (DPD) GENE MUTATION ANALYSIS(D0043)[MP10] | | 8700 |
| DIRECT LDL CHOLESTEROL[1] | | 1030 |
| DMD MLPA [LI21] | | 14900 |
| DNA (DOUBLE STRAND) ANTIBODY- FARR ASSAY [MP8] | | 2630 |
| DNA EXPRESS PATERNITY TEST -M/F+C -LEGAL[DDL15] | | 62370 |
| DNA EXTRACTION [HH5] | | 5890 |
| DNA PATERNITY TEST(1P) [DLI10] | | 14900 |
| DNA STORAGE 1YEAR [LI] | | 4350 |
| DNA TESTING FOR RELATIONSHIP (STR ANALYSIS)[DFL5] | | 29800 |
| DNA TESTING FOR RELATIONSHIP- ADDITIONAL COST FOR STAT REPORTING | | 8610 |
| DNA TESTING FOR RELATIONSHIP(MT DNA ANALYSIS)[DFL5] | | 29800 |
| DNA TESTING FOR RELATIONSHIP(YSTR ANALYSIS)[DFL5] | | 29800 |
| DONOR SPECIFIC ANTOBODY[HH2] | | 6170 |
| DOPAMINE [MP8][D0037] | | 3300 |
| DOUBLE MARKER TEST (1ST TRIMESTER) [LI5] | | 3110 |
| DPD ENZYME TESTING [TH15] | | 20860 |
| DPT ANTIBODIES[MP7][D0044] | | 8570 |
| DUCHENNE MUSCULAR DYSTROPHY DMD PCR TEST [RLS3] | | 10030 |
| DUPLICATE REPORTS - PATHOLOGY | | 110 |
| DYSTONIA GENE PANEL [SL40] | | 25410 |
| E2 (ESTRADIOL)[1] | | 1300 |
| ESTRIOL, SERUM(E0005)[MP2] | | 1300 |
| Hydatid Cyst Detection, Fluid(H0287)[MP2] | | 1040 |
| ECHINOCOCCUS - IGG ANTIBODY, SERUM(E0016)[MP5] | | 2000 |
| EGFR 1790 MUTATIONS [OQ10] | | 16200 |
| EGFR AND KRAS [MB30] [AC12] | | 17010 |
| EGFR MUTATION DETECTION (EXONS -18, 19, 20, 21), FFPE TISSUE(E0043)[MP7] | | 15000 |
| ELECTROLYTE PROFILE [MP2] | | 860 |
| ELECTROLYTES[1] | | 920 |
| ELECTROLYTES BY CAPILLARY METHOD [1] | | 870 |
| ENA (EXTRACTABLE NUCLEAR ANTIGEN) PROFILE (ANTIBODIES TO SSA , SSB , RNP - SM, SCL- 70, JO-1) [MP5] | | 11700 |
| ENDOMYSIAL ANTIBODY IGA [MP5][E0027] | | 2970 |
| ENDOMYSIAL ANTIBODY IGG[MP8][E0028] | | 3870 |
| ENHANCED DOUBLE MARKER TEST [LI5] | | 4970 |
| ENTEROCOCCUS SPECIES PCR DETECTION [MPE011][IG4] | | 4640 |
| ENTEROVIRUS REAL TIME PCR [IG2] | | 4640 |
| ENZYMES GALACTOSEMIA [NG15] | | 25840 |
| EPO - ERYTHROPOIETIN [MP2][E0035] | | 2970 |
| EPSTEIN BARR VIRUS (EBV NA IGG)NUCLEAR ANTIGEN IGG ANTIBODIES[MP8][E0010] | | 2590 |
| EPSTEIN BARR VIRUS (EBV NA IGM)NUCLEAR ANTIGEN IGM ANTIBODIES[MP5][E0012] | | 2720 |
| EPSTEIN BARR VIRUS (EBV VCA IGG) VIRAL CAPSID ANTIGEN IGG ANTIBODIES IGG [MP8][E0011] | | 2580 |
| EPSTEIN BARR VIRUS (EBV VCA IGM) VIRAL CAPSID ANTIGEN IGM ANTIBODIES IGM[MP2][E0013] | | 2330 |
| EPSTEIN-BARR VIRUS (EBV) DNA PCR (2136)QUALITATIVE [MP5] | | 5300 |
| ESR (ERYTHROCYTE SEDIMENTATION RATE)[1] | | 200 |
| ESTRONE, SERUM**(E0042)[MP24] | | 9300 |
| EVEROLIMUS BY LCMS METHOD [MP2] | | 7600 |
| EXTENDED COMPREHENSIVE CNS / PAN ENCEPHALITIS PANEL [IG3] | | 50910 |
| EXTENDED COMPREHENSIVE CNS ANY 20 / PAN ENCEPHALITIS PANEL[IG3] | | 29410 |
| EXTENDED GENE MUTATION ANALYSIS GERMLINE TEST [MULTI GENES] [SL21] | | 34710 |
| EXTENDED PNEUMONIA MULTIPLEX PANEL [IF2] | | 31050 |
| EXTENDED RAS TEST (KRAS,BRAF,NRAS,PIK3CA) -FFPE TISSUE [MP11] | | 21500 |
| FACTOR II (PROTHROMBIN) MUTATION DETECTION [P0109][MP9] | | 7250 |
| FACTOR IX ACTIVITY [MP2][F0006] | | 2510 |
| FACTOR IX INHIBITOR ASSAY [MBA2] | | 8020 |
| FACTOR V ACTIVITY FUNCTIONAL [MP25][F0003] | | 7250 |
| FACTOR V LEIDEN MUTANT DETECTION (G1691A MUTATION), EDTA BLOOD(F0002)[MP5] | | 7200 |
| FACTOR V PROACCELERIN ACTIVITY [MP5] | | 5500 |
| FACTOR VII ACTIVITY PROCONVERTIN[MP10][F0004] | | 5160 |
| FACTOR VIII ACTIVITY[1] | | 4550 |
| FACTOR VIII C LEVEL [MB2] | | 4970 |
| FACTOR X ACTIVITY[MP11] | | 6140 |
| FACTOR XA ANTIBODY[MP6][F0008] | | 6840 |
| FACTOR XI ACTIVITY [MP11][F0009] | | 4960 |
| FACTOR XII ACTIVITY HAGEMAN CITRATED PLASMA [MP15] | | 4870 |
| FACTOR XIII ACTIVITY , QUALITATIVE (1957)[SR2] | | 3600 |
| FERRITIN[1] | | 1720 |
| FETAL AUTOPSY [LI30] | | 7200 |
| ACUTE FEVER MULTIPLEX PANEL (8 PATHOGEN) [IF2] | | 7200 |
| FIBRIN DEGRADATION PRODUCTS FDP [MP2][F0015] | | 1880 |
| FIBRINOGEN[1] | | 1300 |
| FIBROBLAST GROWTH FACTOR FGF23 [MP28] | | 12820 |
| FIBROMETER ALD - ALCOHOL RELATED LIVER DISEASE [4511][SR11] | | 6030 |
| FIBROMETER VIRUS- VIRAL HEPATITIS [4590][SR4] | | 6030 |
| FILARIA ANTIBODY [MP2][F0029] | | 1480 |
| FILARIA ANTIGEN [MP2][F0030] | | 1330 |
| FISH 22Q 11.2 MICRODELETION [LI21] | | 8700 |
| FISH 5 PROBE (13,18,21,X,Y) POC [LI5] | | 8700 |
| FISH AMNIOTIC FLUID-QF-PCR 13,18,21,X,Y[LI4] | | 7400 |
| FISH CHIMERISM -STR [GG15] | | 14810 |
| FISH CHIMERISM X Y [GG6] | | 10690 |
| 22q Deletion ( Microdeletion Digeorge Syndrome), Heparin Blood(#0036)[MP8] | | 9700 |
| FISH FOR HER2/NEU/CERB2/ERBB2 [NB14] | | 15400 |
| FISH FOR HER2 [TH20] | | 27900 |
| ONCOINSIGHTS™ FISH PANEL MULTIPLE MYELOMA[LI7] | | 24800 |
| FISH FOR MYLOPROLIFIRATIVE DISCORDER [7Q,20Q,4Q12 WITH CHIC2 AND 5Q33]LI5] | | 15800 |
| FISH FOR PRADER-WILLI-ANGELMAN SYNDROME [LI22] | | 10040 |
| ROS1 TRANSLOCATION[LI7] | | 11000 |
| FISH FOR TRISOMY 21 [LI3] | | 7900 |
| ONCOINSIGHTS™ FISH PANEL MDS[LI6] | | 15400 |
| ONCOINSIGHTS™FISH PANEL CLL[LI14] | | 22100 |
| ONCOINSIGHTS™FISH PANEL FOR TRIPLEHIT LYMPHOMA (HIGH GRADE B-CELL LYMPHOMA) (BMA/PB) [LI5] | | 18700 |
| FISH- 22Q MICRODELETION SYNDROME[LI4] | | 10000 |
| FL1P1-PDGFR (LI5) | | 5800 |
| FLOW CYTOMETRY FOR LEUKEMIAS / LYMPHOMAS / MYELOMA [SL4] | | 20060 |
| FLOW CYTOMETRY FOR MINIMAL RESIDUAL DISEASE (MRD) FOR B-ALL T-ALL | | 33000 |
| FLT MUTATIONS - FLT3-ITD AND D835 [LI3] | | 7820 |
| FLT-3 (AML) MUTATION PANEL, EDTA BLOOD(F0032)[MP10] | | 7600 |
| FLUID - OCCULT BLOOD[1] | | 300 |
| FLUID AMYLASE [1] | | 680 |
| FLUID BILE SALTS and BILE PIGMENTS [1] | | 200 |
| FLUID CYTOLOGY EXAMINATION BIREFRINGENT CRYSTAL WITH POLORIZATION MICROSCOPY(P0073) [MP5] | | 3200 |
| FLUID CYTOSPIN [SL2] | | 1580 |
| FLUID DIFFERENTIAL COUNT [1] | | 760 |
| FLUID FAT GLOBULES [1] | | 200 |
| FLUID GLUCOSE [1] | | 500 |
| FLUID LDH [1] | | 530 |
| FLUID PH [1] | | 200 |
| FLUID PROTEIN [1] | | 500 |
| FLUID UREA [1] | | 500 |
| FNAC SECOND OPINION [3] | | 1300 |
| FOLIC ACID / FOLATE[1] | | 1900 |
| FOLIC ACID FROM RBC [MP2][R0007] | | 2850 |
| FOOD ALLERGEN PANEL [PR4]][7968] | | 14900 |
| FOOD INTOLERANCE (FOOD IGG) TEST, SERUM(F0048)[MP4], | | 22400 |
| FOUNDATION 1 CDX (324 GENE /TBM/MSI/PDL1(FM25) | | 337700 |
| FRAGILE X SYNDROME BY PCR [MG20] | | 12920 |
| FRAGILE X TEST-MOLECULAR STUDY-FEMALE [LI31] | | 12420 |
| FRAGILE-X TEST-MOLECULAR STUDY-MALE [LI31] | | 8700 |
| FREE ANDROGEN INDEX [F0052][MP2] | | 4210 |
| FREE HAEMOGLOBIN[H0003][MP7] | | 1440 |
| FREE LIGHT CHAIN ASSAY- SERUM [KAPPA and LAMBDA] [MP3] | | 6170 |
| FREE METANEPHRINE PLASMA[M0039] [MP5] | | 6810 |
| FREE NOR METANEPHRINE PLASMA [MP5][N0036] | | 5960 |
| FREE PSA ( PROSTATE SPECIFIC - ANTIGEN - FREE MOLECULE )[1] | | 1960 |
| FREE T3 - FREE TRIIODOTHYRONINE[1] | | 970 |
| FREE T4 - FREE THYROXINE[1] | | 970 |
| FREE TESTOSTERONE [MP3][T0041] | | 2600 |
| FREE THYROID PROFILE - FT3, FT4 AND TSH[1] | | 2280 |
| FRIEDREICH ATAXIA MUTATION ANALYSIS [MP8][F0051] | | 9290 |
| FROZEN SECTION FOLLOWUP REPORTING[1] | | 4500 |
| FROZEN SECTION REPORTING [1] | | 8500 |
| FRUCTOSAMINE [MP4][F0056] | | 1420 |
| FSH (FOLLICLE STIMULATING HORMONE[M,W,F][2] | | 1180 |
| FUNGAL CULTURE - BLOOD-7D- FLUID,PUS,SWAB,URINE-14D - SKIN,NAIL, HAIR-28D | | 1900 |
| FUNGAL SENSITIVITY (CANDIDA) [4] | | 4300 |
| FUNGAL SMEAR FOR MUCORMYCOSIS[1] | | 900 |
| FUNGAL SMEAR/ WET/KOH MOUNT PREPARATION.[1] | | 500 |
| FUNGAL SUSCEPTIBILITY MIC YEAST[HH5] | | 5500 |
| G6PD QUALITATIVE(GLUCOSE 6-PHOSPHATE DEHYDROGENASE)[1] | | 970 |
| G6PD QUANTITATIVE ESTIMATION [PK2][HM24] | | 1120 |
| GAD-65 FOR PARANEOPLASTIC SYNDROME (GLUTAMIC ACID DECARBOXYLASE) ANTIBODY [MP8][G0058] | | 8700 |
| GAD-65 FOR TYPE I DIABETES (GLUTAMIC ACID DECARBOXYLASE) ANTIBODY [MP4][G0004] | | 7710 |
| GALACTOMANNAN [IF4] | | 7180 |
| GAMMA GLUTAMYL TRANSFERASE(GGT)[1] | | 500 |
| Ganglioside - IgG antibody, Serum(G0012)[MP8] | | 5000 |
| GANGLIOSIDE - IGM ANTIBODY, SERUM(G0013)[MP8] | | 5000 |
| GASTRIN –FASTING [MP3][G0016] | | 1880 |
| GASTRO DUODENAL BIOPSY - LIGHT MICROSCOPY WITH SPECIAL STAINS [6] | | 2300 |
| GASTRO INTESTINAL BIOPSY (MULTIPLE) [5] | | 5200 |
| GASTROENTERITIS BACTERIAL PANEL BY PCR[MP4] | | 7720 |
| GASTROENTERITIS VIRAL PANEL BY MULTIPLEX PCR [MP3] | | 7900 |
| GASTROINTESTINAL PANEL BY FILMARRAY [MP2][G0324] | | 22970 |
| GBM (GLOMERULAR BASEMENT MEMBRANE) ANTIBODY, SERUM(G0017)[MP5] | | 2300 |
| GENE ANALYSIS (THROMBOTIC THROMBOCYTOPENIC PURPURA TTP ADAMTS13 ] [MG30] | | 56300 |
| GENE ANALYSIS RBC MEMBRANE DISORDERS AND ENZYMOPATHIES BY NGS [MP30] | | 24830 |
| PRADER-WILLI / ANGELMAN SYNDROME, EDTA BLOOD(P1008)[MP10] | | 8700 |
| GENETIC STUDY FOR EPISODIC ATAXIA PANEL [MED45] | | 52440 |
| GENEXPERT MTB (MYCOBACTERIUM TUBERCULOSIS)[1] | | 3300 |
| GENEXPERT XDR [IF2] | | 5300 |
| GERMLINE 3 GENE TEST [SL21] | | 24400 |
| GFR GLOMERULAR FILTERATION RATE [1] | | 1180 |
| GIARDIA ANTIGEN DETECTION [G0021][MP2] | | 1500 |
| GIEMSA STAINING [1] | | 300 |
| GLYCINE [NL4] | | 10040 |
| GLYCOSYLATED HAEMOGLOBIN (HBA1C)[1] | | 1380 |
| GMI GANGLIOSIDOSIS, QUANTITATIVE -BLOOD [GM123][LL10] | | 3300 |
| GRAM STAINING[1] | | 500 |
| GROWTH HORMONE [MP2] | | 1230 |
| HAEMOPHILIA A (F8) DELETION / DUPLICATION ANALYSIS [MG16] | | 12340 |
| HAINS TEST- TB GENOTYPE DRUG RESISTANCE TEST(2 ND LINE) [IF5] | | 9000 |
| HAINS TEST-TB GENOTYPE DRUG RESISTANCE TEST(1ST LINE) [IF4] | | 4700 |
| HANTA VIRUS IGM ANTIBODIES [MP4] | | 3400 |
| HAPTOGLOBIN, SERUM(H0014)[MP2] | | 2600 |
| HB and PCV (HAEMOGLOBIN + PCV)[1] | | 400 |
| HB ELECTROPHORESIS (HAEMOGLOBIN VARIANT ANALYSIS) [A0001][MP2] | | 1500 |
| ANTI HBCAG - IGM, SERUM(H0027)[MP2] | | 1400 |
| HBDH ENZYMATIC [MP4] | | 680 |
| Anti HBeAg, Serum(H0028)[MP2] | | 1300 |
| HBEAG ( HEPATITIS B ENVELOPE ANTIGEN) [MP2] | | 1500 |
| HBSAG BY CHEMILUMINESENCE[1] | | 780 |
| HBSAG BY RAPID METHOD[1] | | 2280 |
| HBSAG ULTRA BY ELFA[1] | | 1180 |
| HBV - DNA QUANTITATIVE ( VIRAL LOAD)[1] | | 9300 |
| HBV (HEPATITIS B VIRUS) DNA DETECTION BY TAQMAN, SERUM OR PLASMA(H0030)[MP2] | | 5200 |
| HCG BETA SUBUNIT, CSF [H0046][MP2] | | 2250 |
| HCV BY CHEMILUMINESENCE[1] | | 1180 |
| HCV (HEPATITIS C VIRUS) TOTAL ANTIBODY REFLEX HCV-RNA PCR QUALITATIVE, SERUM(H0302) | | 8500 |
| HCV BY RAPID METHOD[1] | | 1420 |
| HCV GENOTYPING[H0052][MP5] | | 9200 |
| HCV IGG ANTIBODY ( ANTI HCV )[1] | | 1700 |
| HCV IGM ANATIBODY | | 1900 |
| HCV (HEPATITIS C VIRUS) RNA DETECTION BY TAQMAN, SERUM OR PLASMA(H0054) | | 6600 |
| HCV RNA QUANTITATIVE (VIRAL LOAD)[1] | | 12170 |
| HDL CHOLESTEROL DIRECT[1] | | 500 |
| HEAVY METALS FOR AYURVEDIC TABLETS TEST(H0329)[MP13] | | 6840 |
| HEINZ BODIES [MP2] | | 290 |
| HELICOBACTER PYLORI - IGA ANTIBODY, SERUM((H0065)[MP6] | | 2740 |
| HELICOBACTER PYLORI - IGG ANTIBODY, SERUM(H0066)[MP2] | | 2740 |
| HELICOBACTER PYLORI IGM(7986) [MP5][H0067] | | 3050 |
| HEMOCHROMATOSIS PANEL[MG21] | | 27320 |
| Haemophilia Profile(H0005)[MP8] | | 5000 |
| HEPARIN INDUCED THROMBOCYTOPENIA (HIT) ANTIBODIES [MP5][H0198] | | 6460 |
| HEPATITIS B PROFILE [MP5] [H5671] | | 12810 |
| HEPATITIS B VIRUS (HBV) HBSAG-QUANTITATIVE SURFACE ANTIGEN[H0039][MP2] | | 1550 |
| HEPATITIS B VIRUS (HBV) HBV-DNA DETECTION BY RT PCR CSF [H0033][MP7] | | 5340 |
| HEPATITIS B VIRUS (HBV) HBV-GENOTYPING SERUM OR PLASMA [H0035 ][MP5] | | 10540 |
| HBV (HEPATITIS B VIRUS) GENOTYPE & DRUG RESISTANCE, SERUM OR PLASMA(H0035)[MP9] | | 9900 |
| HEV (Hepatitis E Virus) - IgM antibody, Serum(H0080)[MP2] | | 1900 |
| HEPATITIS MARKER PROFILE , ACUTE [MP2] [H0074 | | 4600 |
| HEPATITIS PROFILE COMPLETE [MP5][H0075] | | 8590 |
| HEREDITARY PANCREATITIS GENE PANEL(M309) [MG309] | | 21120 |
| HERIDITARY CANCEL PANEL [MP30] | | 25830 |
| HERPES SIMPLEX VIRUS -1 IGG (HSV 1 IGG)[MP2][H0268] | | 990 |
| HERPES SIMPLEX VIRUS -1 IGM (HSV 1 IGM)[MP2][H0269] | | 990 |
| HERPES SIMPLEX VIRUS -2 IGG (HSV 2 IGG)[MP2][H0282] | | 990 |
| HERPES SIMPLEX VIRUS -2 IGM (HSV 2 IGM)[MP2][H0283] | | 990 |
| HERPES SIMPLEX VIRUS DNA DETECTOR(CSF-H0271/SERUM-H0272) [MP4] | | 5690 |
| HERPES ZOSTER VIRUS PCR - CSF[IF2] | | 4590 |
| HEV IGG ANTIBODY[MP6] | | 1870 |
| HIRSUTISM PROFILE - 2, SERUM**(H0083)[MP5] | | 6800 |
| HISTAMINE[H0085][MP21] | | 8980 |
| HISTONE ANTIBODY, SERUM(H0132)[MP5] | | 2300 |
| HISTOPATH SECOND OPINION [TH10] | | 19700 |
| HISTOPATH SECOND OPINION -BONE MARRAOW SMEAR and BIPOSY [SL2.8] | | 10000 |
| HISTOPATHOLOGY SECOND OPINION -BLOCKS 10+[NB10] | | 16200 |
| HISTOPATHOLOGY SECOND OPINION -BLOCKS 1-10[NB10] | | 14700 |
| HISTOPATHOLOGY / CYTOLOGY DEPOSIT - SLIDES AND BLOCKS | | 800 |
| HISTOPATHOLOGY / CYTOLOGY SECOND OPINION [3] | | 4700 |
| HISTOPATHOLOGY EXMAINATION[NB6] | | 12900 |
| HISTOPATHOLOGY LARGE[6] | | 3400 |
| HISTOPATHOLOGY MEDIUM [4] | | 2300 |
| HISTOPATHOLOGY RADICAL[7] | | 4200 |
| HISTOPATHOLOGY SKIN BIOPSY SECOND OPINION [HH6] | | 3400 |
| HISTOPATHOLOGY SMALL [4] | | 1500 |
| HISTOPATHOLOGY SPECIAL STAINS ON BLOCKS | | 2300 |
| HIV 1 and 2 BY CHEMILUMINESENCE[1] | | 970 |
| HIV 1 and 2 BY RAPID METHOD[1] | | 1030 |
| HIV 1 EARLY DETECTION BY PROVIRAL DNA[H0201][MP2] | | 5000 |
| HIV -1 RNA DETECTION (QUALITATIVE)[H0202][MP3] | | 4500 |
| HIV 1 VIRAL LOAD BY TAQMAN CSF | | 7700 |
| HIV 2 RNA DETECTION BY RT PCR[H0209][MP4] | | 5200 |
| HIV 2 VIRAL LOAD BY RT PCR | | 7800 |
| HIV DUO ULTRA[1] | | 1530 |
| HIV MONITOR ( VIRAL LOAD, CD4/ CD8)[H0206]MP3] | | 9300 |
| HIV-1 (Human Immunodeficiency Virus Type 1) RNA Quantification (Viral load) by Taqman, EDTA Plasma[H | | 7300 |
| HIV WESTERN BLOT[H0205][MP2] | | 5400 |
| HIV-1 GENOTYPIC RESISTANCE[SR12] | | 17400 |
| HLA B50 [HH5] | | 5740 |
| HLA – DR / DQ [4852B] [SR5] | | 13040 |
| HLA INTERPREATION WITH DONOR and RECIPIENT REPORTS [1] | | 1900 |
| HLA B27 [MP2][H0250] | | 3050 |
| HLA B27 PCR [1348] [MP3] | | 4450 |
| HLA CROSS MATCHING(CDC) [HH2] | | 2980 |
| HLA CROSS MATCHING(FLOWCYTOMETRY) [HH2] | | 6220 |
| HLA TYPING [HIGH RESOLUTION] 6 LOCI [HG15] | | 32400 |
| HLA TYPING [HIGH RESOLUTION] 7 LOCI [HG15] | | 37260 |
| HLA TYPING A,B,C, DP, DQ, DR HIGH RESOLUTION [MP11] | | 18600 |
| HLA TYPING A,B,C, DR1 FOR DONOR WITH LOW RESOLUTION [JH7] | | 27800 |
| HLA TYPING DONOR [ (A,B,C,DR,DP,DQ) BY PCR-SSO[HH4] | | 32300 |
| HLA TYPING RECIPIENT (A,B,C,DR,DP,DQ) BY PCR-SSO[HH4] | | 32300 |
| HLA TYPING-MOLECULAR B51 LOCUS [H0222][MP3] | | 11720 |
| HLA-B-5701 (H0249)[MP8] | | 3980 |
| HLH STUDY [KEM2] | | 4730 |
| HMGCR ANTIBODY DETECTION[MP30][H0872] | | 13280 |
| HNF1 ALPHA MUTATION [MG21] | | 20090 |
| HOLO TRANSCOBALAMIN ( VITAMIN B12 ACTIVE[V0011] [MP2] | | 1880 |
| HOMA INDEX ( INSULIN/C-PEPTIDE RESISTANCE TEST SERUM AND FLUORIDE) [H0253] [MP2] | | 1550 |
| HOMOCYSTEINE SPOT URINE [MP6] | | 1750 |
| HOMOCYSTEINE[M,W,F][2] | | 1900 |
| HOMOLOGOUS RECOIMBINATION DEFICIENCY HRD ON BLOCK [SL25] | | 86900 |
| H-RAS [AC12] | | 10800 |
| HS CRP - HIGH SENSITIVE C-REACTIVE PROTEIN[1] | | 1030 |
| HSV 1 and 2 IGG ANTIBODY- WESTERN BLOT (H0277)[MP4] | | 3160 |
| HTLV 1 & 2 VIRUS TOTAL ANTIBODY, SERUM(H0284)[MP8] | | 6200 |
| H-TTG-DGP [9979][SR4] | | 2860 |
| HU ( NEURONAL ANTIGEN ) ANTIBODY [H0285] [MP2] | | 5930 |
| HUMAN EPIDIDYMIS PROTEIN 4 (HE4) WITH ROMA INDEX [M,W,F][2] | | 4100 |
| HUMAN PAPILLOMA VIRUS (HPV -HIGH RISK TYPE) DETECTION BY RTPCR (GENEXPERT)[1] | | 4000 |
| HUNTINGTONS DISEASE [MP9][H0286] | | 7270 |
| HYPERCOAGULATION - THROMBOPHILLIA PROFILE -SUPER [MP8]][T0507] | | 27320 |
| HYPERSENSITIVITY PNEUMONITIS PANEL(HP PANEL)[MP4] | | 9310 |
| HYPERTROPHIC CARDIOMYOPATHY GENETIC TESTING [DL32] | | 56690 |
| IA2 INSULIN AUTOANTIBODIES [I0001] [MP5] | | 3550 |
| ICHTHYOSIS GENE PANLE[LI22] | | 35880 |
| IDH1 AND IDH2 GENE MUTATION [MP8] | | 8480 |
| IGA TOTAL ANTIBODY BY IMMUNOTURBIDIMETRY, SERUM(I0006)[MP2] | | 900 |
| IGE (IMMUNOGLOBULIN E) [1] | | 1220 |
| IGG – CSF [I0011] [MP2] | | 2010 |
| IgG Total antibody by Immunoturbidimetry, Serum (I0012)[MP2] | | 900 |
| IGG-4 [I0013] [MP2] | | 8950 |
| IGHV MUTATIONS [LI11] | | 13040 |
| IGLON5 ANTIBODY BY IFA, SERUM(I0397)[MP5] | | 23900 |
| IgM Total antibody by Immunoturbidimetry, Serum(I0016)[MP2] | | 900 |
| IHA FOR AMOEBIASIS / AMOEBIASIS ANTIBODIES IGG (A0428)[MP5] | | 1810 |
| INTERLEUKIN-6, EDTA PLASMA(I0279)[MP2] | | 4000 |
| IMMUNODEFICIENCY TEST-LAD-1 and NBT [KEM5] | | 5190 |
| IMMUNOFIXATION -SERUM-QUALITATIVE(MP4) | | 6960 |
| IMMUNOGLOBULIN G HEAVY AND LIGHT CHAIN REARRANGEMENT BY PCR[TH-A21] | | 33540 |
| IMMUNOHISTOCHEMISTRY (IHC) 1 ANTIBODY[10] | | 3400 |
| IMMUNOHISTOCHEMISTRY (IHC) 3-5 ANTIBODIES[10] | | 10300 |
| IMMUNOHISTOCHEMISTRY (IHC) 6-8 ANTIBODIES(10) | | 14700 |
| IMMUNOHISTOCHEMISTRY (IHC) ER PR AND HER2NEU[10] | | 7300 |
| IMMUNOHISTOCHEMISTRY(IHC) ER PR HER2NEU AND KI-67[10] | | 9300 |
| IMMUNOREACTIVE TRYPSINOGEN TEST [NL7] | | 2150 |
| INDIA INK PREPARATION [1] | | 400 |
| INFLUENZA VIRAL PANEL WITH H1N1 VIRUS (F0119)[MP2] | | 7500 |
| INHALATION ALLERGEN PROFILE [PR4] | | 18510 |
| INHIBIN A ( DIMERIC ) [MP2][I0273] | | 1610 |
| INHIBIN B [I0274][MP5] | | 2970 |
| INSULIN - POST GLUCOSE[M,W,F][2] | | 1400 |
| INSULIN - RANDOM[M,W,F][2] | | 1400 |
| INSULIN - FASTING[M,W,F][2] | | 1400 |
| INSULIN - POST PRANDIAL[M,W,F][2] | | 1400 |
| INSULIN GROWTH FACTOR ( IGF) 1 (SOMATOMEDIN C)(MP2)[I0009] | | 4540 |
| IGF-BP3, Serum(I0008)[MP2] | | 4300 |
| INTEGRATED SCREENING MARKER TEST (15-19) [LI3] | | 3210 |
| INTRINSIC FACTOR ANTIBODY [PR5][ | | 2860 |
| INVASIVE FUNGAL PNEUMONIA MULTIPLEX [PC289] [IF2] | | 18640 |
| IONISED CALCIUM[1] | | 1030 |
| IPT - AML MRD (I0060)[UP3] | | 13700 |
| IRON STUDIES (IRON AND TIBC)[1] | | 1220 |
| ISLET CELL ANTIBODY, SERUM(I0287)[MP5] | | 3300 |
| ISONIAZID DRUG LEVEL [HH7] | | 7500 |
| I-STAT CG8+ Blood Gas[1] | | 1390 |
| I-STAT CG4 BLOOD GAS AND LACTATE] | | 1810 |
| I-STAT CREATININE [1] | | 790 |
| I-STAT E4+ [NA,K,HCT, HB,GLU[1] | | 1200 |
| ITRACONAZOLE LEVEL [HH8] | | 10200 |
| JAK2 EXON 12 MUTATION DETECTION, EDTA BLOOD(J0003)[MP10] | | 8600 |
| JAK2 V617F MUTATION DETECTION BY RT-PCR, EDTA BLOOD(J0004)[MP5] | | 8600 |
| JAPANESE ENCEPHALALITIS –CSF (RD1420)[SR5] | | 3660 |
| JC-BK Virus DNA Detection by RT-PCR, Plasma(J0006)[MP5] | | 7700 |
| JC-BK VIRUS DNA DETECTION BY RT-PCR, CSF(J0005)[MP5] | | 7700 |
| JC VIRUS RT PCR (QUANTITATIVE) [RD1471][SR8] | | 7970 |
| JO-1 ANTIBODY [MP5] | | 2860 |
| JUVENILE HH DNA TEST [SD30] | | 30300 |
| LEISHMANIA (RK39) ANTIBODY DETECTION, SERUM**(K0023)[MP6] | | 2600 |
| KAOLIN CLOTTING TIME, CITRATED PLASMA(K0018)[MP2] | | 2000 |
| KARYOTYPIG POC/ CHORIONIC VILLI/PLACENTA/SKIN/AMNIOTIC FLUID)[LI23] | | 8700 |
| KARYOTYPING BLOOD[LI12] | | 4850 |
| KARYOTYPING BY HIGH RESOLUTION BANDING [MP13] | | 6450 |
| KIDNEY BIOPSY - ELECTRON MICROSCOPY [JH18] | | 15000 |
| KIDNEY BIOPSY – IMMUNOFLUORESCENCE [MP8][I0378] | | 4700 |
| KIDNEY BIOPSY - LIGHT MICROSCOPY WITH SPECIAL STAINS[10] | | 2900 |
| KIDNEY BIOPSY LIGHT MICROSCOPY[HH6] | | 3900 |
| KIT GENE ANALYSIS 4 EXONS 9-11-13-17[MG10] | | 20400 |
| K-RAS MUTATION (MB66)[AC12] | | 10800 |
| L.E.(LUPUS ERYTHEMATOSUS) CELLS[MP2] | | 600 |
| LACTATE DEHYDROGENASE(LDH)[1] | | 580 |
| LACTATE ON FUSION[1] | | 1220 |
| LACTOSE TOLERANCE TEST 5 SAMPLES FOR GLUCOSE PLASMA [L0003][MP2] | | 800 |
| LAMOTRIGINE [MP8][L0006] | | 5660 |
| LDH ISOENZYMES [MP8] [L0016] | | 6060 |
| LEAD LEVEL WHOLE BLOOD [MP2][L0019] | | 2770 |
| LEGIONELLA PNEUMOPHILA IGG ANTIBODY [MP5][L0027 | | 3550 |
| LEGIONELLA PNEUMOPHILA IGM ANTIBODY [MP5][L0028] | | 3750 |
| LEISHMANIA (RK 39) ANTIBODY, [KALA-AZAR [9074][SR2] | | 2400 |
| LEPTIN, SERUM[L0034][MP9] | | 5500 |
| LEPTOSPIRA IGG and IGM RAPID [1] | | 1340 |
| Leptospira - IgG antibody, Serum(L0040)[MP2] | | 1600 |
| LEPTOSPIRA IGM ELISA [MP2] | | 1870 |
| LEPTOSPIRADNA DETECTION BY RT PCR - BLOOD(L0038)[MP2 | | 2890 |
| LEUCOCYTE ALKALINE PHOSPHATASE ( LAP ) / NEUTROPHIL ALKALINE PHOSPHATASE ( NAP ) SCORE [MP4] | | 1670 |
| ONCOINSIGHTSâ„¢ FISH PANEL - AML[LI6] | | 22100 |
| LEUKEMIA / CYTOGENTICS / LYMPHOMA EVALUATION PANEL-2 ( MT RT PCR)/CUSTOM LEUKEMIA PANEL (SIX S [SR9] | | 14280 |
| LEUKEMIA / LYMPHOMA EVALUATION WITH IMMUNOHISTOCHEMISTRY AND HISTOPATHOLOGY [SR1674S] [SR6] | | 10400 |
| LEUKEMIA EOSINOPHILIA PANEL BY FISH(L0052) [MP6] | | 15790 |
| ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) TRANSLOCATION PANEL BY RT-PCR, EDTA BLOOD(L0117)[MP8] | | 9100 |
| LEVETIRACETAM[ L1008] [MP11] | | 7720 |
| LH (LEUTINISING HORMONE)[M,W,F][2] | | 1100 |
| LHH 12 + 2 FASTING [1] | | 5300 |
| LHH 15 FASTING [1] | | 5690 |
| LHH12 + 2 RANDOM [1] | | 5300 |
| LIPASE[1] | | 1070 |
| LIPID PROFILE[1] | | 1680 |
| LIPOPROTEIN A[M,W,F][2] | | 1000 |
| LIPOPROTEIN ELECTROPHORESIS [MP8] | | 3500 |
| LIQUID BIOPSY FOR COLON CANCER [DL15] | | 46270 |
| LISTERIA ANTIBODY, CF (90048) [SR18] | | 23400 |
| LITHIUM LEVEL [MP2] | | 920 |
| LIVER BIOPSY - HISTOPATHOLOGY [BH4] | | 5700 |
| LIVER BIOPSY - LIGHT MICROSCOPY WITH SPECIAL STAINS [6] | | 4700 |
| LIVER CYTOSOLIC ANTIGEN TYPE-1 LC-1 ANTIBODY [MP8] | | 4020 |
| LIVER PROFILE WITHOUT GGT ONLY HC | | 1900 |
| LIVER PROFILE[1] | | 2450 |
| LKM1 - ANTIBODIES TO LIVER KIDNEY MICROSOMES (QUALITATIVE) MP[5] | | 2590 |
| LP-PLA2 PLAC[L0103] [MP4] | | 3300 |
| LUNG PANEL BY NGS and PD-L1 (SP263)(MGM1493)[MG25] | | 34800 |
| LUPUS ANTICOAGULANT (RVVT METHOD) [PR2] | | 2510 |
| LYME BORRELIA BURGDORFERI IGM BY WESTERNBLOT METHOD[B1017] [MP35] | | 9260 |
| LYME DISEASE (BORRELIA BURGDORFERI ) IGG [MP8] | | 2390 |
| LYME DISEASE (BORRELIA BURGDORFERI )IGM [MP8] | | 3420 |
| LYME DISEASE ANTIBODY, IMMUNOBLOT, SPINAL FLUID(CSF)[SR25] | | 23200 |
| LYMPHOCYTE ENUMERATION - BASIC AND NK CELLS [SL2] | | 8610 |
| LYMPHOCYTE SUBSET PANEL [MP3] | | 9900 |
| LYMPHOMA PANEL [ SL2] | | 18660 |
| LYNCH SYNDROME-GERMLINE PANEL [LI30] | | 31970 |
| MAG ANTIBODIES DEMYELINATING DISORDERS [MP15] | | 6170 |
| MAGNESIUM[1] | | 680 |
| MALARIAL ANTIBODY- IGG [MP2] | | 1370 |
| MALARIAL PARASITE ON SMEAR[1] | | 390 |
| MANGANESE, EDTA BLOOD(M0011)[MP4] | | 4000 |
| MANTOUX TEST ONE STEP - MT PPD TEST [2] | | 300 |
| MANTOUX TEST TWO STEP - MT PPD TEST [14] | | 580 |
| MDM2 GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION (FISH) [LI7] | | 9900 |
| MDS PROGNOSTIFICATION AND RISK STRATIFICATION GENE PANEL [MD15] | | 17390 |
| MEASLES ( RUBEOLA ) IGG ANTIBODIES CSF [MP5][M0021] | | 4390 |
| MEASLES ( RUBEOLA ) IGG ANTIBODIES SERUM [MP2] | | 2300 |
| MEASLES ( RUBEOLA ) IGM ANTIBODIES [MP2] [M0022] | | 2330 |
| MENINGIO ENCEPHALITIS MULTIPLEX CSF | | 31000 |
| MENINGITIS / ENCEPHALITIS PANEL BY FILMARRAY BIOFIRE CSF [MP2] | | 22970 |
| Mercury, Serum(M0033)[MP4] | | 3600 |
| MET AMPLIFICATION TEST [MP8][M0142] | | 13000 |
| METABOLIC SCREEN -NEWBORN BLOOD [NC4] | | 1580 |
| METABOLIC SCREEN -NEWBORN [NG5] | | 8110 |
| METABOLIC SCREEN URINE [NG5] | | 6170 |
| METANEPHRINE PLASMA [MP5] [M0151] | | 9470 |
| METH HEMOGLOBIN [1] | | 1250 |
| METHANAMINE SILVER STAINING FOR PNEUMOCYSTIS CARINII [HH2] | | 1220 |
| METH-HAEMOGLOBIN BLOOD M0044 [MP3] | | 1300 |
| METHOTREXATE LEVEL [HH2] | | 4940 |
| MIB INDEX [Z245K] [SR5] | | 3600 |
| MIC RAPID GROWING MYCOBACTERIUM [IF15] | | 9690 |
| MICM MATERNALLY INHERITED CARDIOMYOPATHY MITOCHONDRIAL DISEASE [MP8][M0051] | | 9120 |
| MICROFILARIA [1] | | 200 |
| MICROSATELLITE INSTABILITY AALYSIS COLORECTAL STR [DL10] | | 22610 |
| MICROSATELLITE INSTABILITY ASSAY ON TUMOR [TH15] | | 10700 |
| MICROSATELLITE INSTABILITY INDEX BY PCR [LI12] | | 14400 |
| MISMATCH REPAIR (MMR) PROTEIN IMMUNOHISTOCHEMISTRY [MP6] | | 10600 |
| MITOCHONDRIAL ( M2 ) ANTIBODY –QUALITATIVE[MP2] [M0055] | | 2590 |
| MITOCHONDRIAL MUTATION PANEL 2 [ LHON, NARP, CPEO, SNHL, DEAF, AMDF ] [MP8][M0061] | | 11100 |
| MIXING STUDIES- COAGULATION[1] | | 1180 |
| MOLECULAR KARYOTYPING(LI15) | | 16200 |
| MOLECULAR PANEL FOR ETP-ALL (FLT3-ITD AND D835) [LI3] | | 9040 |
| MOLECULAR PANEL MPN/MPD JAK 2 EXON 12, MPL AND CALRETICULIN [LI5] | | 18100 |
| MOLECULAR STUDIES [LI3] | | 24690 |
| MOTT SUSCEPTIBILITY [ SLOW GROWER ] [IF30] | | 10690 |
| MPL W515/S505 MUTATION DETECTION, EDTA BLOOD(M0101)[MP12] | | 9100 |
| MPN PANEL WITH BCR ABL1 (BCR ABL QUALITATIVE PCR, JAK 2, EXON14 -V617F and EXON 12, CALR, MPL[LI5] | | 23000 |
| MRSA SCREENING[1] | | 1400 |
| MTB REVIVAL AND CONFIRMATION FOR MGIT/TBDRUGS[HH] | | 1310 |
| MTHFR MUTATION DETECTION [M0070]MP12] | | 10040 |
| MUCOPOLYSACCHARIDOSIS[GI10] | | 23530 |
| MULTIGENE PANEL FOR HEREDITARY CANCER [SL30] | | 36580 |
| MULTIPLE SCLEROSIS PROFILE – MINI [MP5][M0076] | | 7900 |
| MULTIPLE SCLEROSIS PROFILE-MAXI [MP5][M0075] | | 12520 |
| MUMPS VIRUS IGG ANTIBODY, SERUM(M0078)[MP2] | | 2250 |
| MUMPS VIRUS IGM ANTIBODY, SERUM(M00790[MP3] | | 2050 |
| MUSCLE BIOPSY - ELECTRON MICROSCOPY [JH18] | | 16600 |
| MUSCLE BIOPSY - IMMUNOHISTOCHEMISTRY [BH7] | | 18200 |
| MUSCLE BIOPSY - LIGHT MICROSCOPY [BH7] | | 4800 |
| MUSK ANTIBODY [MP5][M0080] | | 8400 |
| MUTATION SPECIFIC TEST [SL30] | | 7180 |
| Myasthenia Gravis Evaluation Panel – Serum[ZLS13] | | 15550 |
| MYCOBACTERIAL IDENTIFICATION BY MALDI TOF MS1400 [IF2] | | 2880 |
| MYCOBACTERIUM ADDITIONAL SPECIES IDENTIFICATION [IF3] | | 5870 |
| MYCOBACTERIUM PANELS - TB CERTIFY [IG3] | | 11720 |
| MYCOBACTERIUM SPECIES IDENTIFICATION [IF3] | | 5870 |
| MYCOPLASMA PNEUMONIA IGG [MP9] | | 2770 |
| MYCOPLASMA PNEUMONIA IGM [MP5] | | 3050 |
| MYD 88 ANALYSIS [LI7] | | 7510 |
| MYELIN BASIC PROTEIN- MBP [LL15] | | 10030 |
| MYELOID NGS - DNA AND RNA STUDIES [LI15] | | 31570 |
| MYELOPEROXIDASE ( MPO ) - TISSUE [MP5] | | 3300 |
| MYOSITIS IGG(16 ANTIGEN)PROFILE(M0161)[MP2] | | 16150 |
| MYOTONIA CONGENITA GENE PANEL [MGM142][MG32] | | 61710 |
| MYOTONIC DYSTROPHY TYPE 1 -19Q 13.3(M0095)[MP15] | | 10050 |
| NATURAL KILLER CELLS [N0003] [MP4] | | 6260 |
| NEISSERIA GONORRHOEA DNA DETECTION BY RT-PCR, URINE(N0010)[MP5] | | 4300 |
| NEONATAL ALLOIMMUNE THROMBOCYTOPENIA [ NAIT] TEST [IIH-KEM25] | | 6260 |
| NERVE BIOPSY - ELECTRON MICROSCOPY [JH15] | | 16600 |
| NERVE BIOPSY - LIGHT MICROSCOPY [5] | | 2900 |
| NERVE BIOPSY AT NIMS[5] | | 1400 |
| NEURO DEVELOPMENT DISORDER PANEL [SL45] | | 46270 |
| NEURO MYELITIS OPTICS IGG ANTIBODY ( NMO IGG )[MP5] | | 6080 |
| NEUROLOGY PACKAGE[MG60] | | 52440 |
| NEURON SPECIFIC ENOLASE [NSE] [MP5][N0043] | | 4840 |
| PAN NEUROTROPIC VIRUS PANEL BY RT-PCR, CSF(P0135)[MP4] | | 8640 |
| NEXT GENERATION SEQUENCING ON P.BLOCK | | 49700 |
| NICKEL SERUM [MP3] | | 3580 |
| NICOTINE METABOLITE, QUANTITATIVE, SERUM [N0021][MP2] | | 1800 |
| NIPT-INSIGHT ADV (NIPS) [LI15] | | 21000 |
| NITROBLUE TETRAZOLIUM(NBT) REDUCTION TEST [KEM6] | | 5740 |
| NMDA PLUS – NMDA AND VGKC ANTIBODY[SR8] | | 19900 |
| NMDA RECEPTIOR ANTIBODY, SERUM [MP5] [N0028] | | 9900 |
| NMO ANTIBODY AND MOG ANTIBODY CSF [N0061][MP7] | | 9400 |
| NMO ANTIBODY WITH MOG ANTIBODY [N0059][MP2] | | 8450 |
| NMYC GENE AMPLICATION (M0104)[MP15] | | 17900 |
| NOCARDIA SPECIES IDENTIFICATION AND SENSITIVITY [MP16][N0061] | | 4200 |
| NON-INVASIVE PGT-A 1 EMBRYO[GX25] | | 13700 |
| NOONAN [LI30] | | 28600 |
| NOR METANEPHRINE PLASMA [MP5] [N0036] | | 5960 |
| NOTCH3( CADASIL ) GENE ANALYSIS [MGM158] | | 24400 |
| NPHS1 [CG18] | | 84060 |
| N-RAS 20 SNPS MUTATIONS [MB74] [AC12] | | 11600 |
| NRAS Mutations Detection (Exon 2 & 3), FFPE Tissue(N0041)[MP7] | | 7800 |
| NT PRO BNP - BRAIN NATRIURETIC PEPTIDE[1] | | 5200 |
| NTM CULTURE FOR ATYPICAL MYCOBACTERIUM SPECIES IDENTIFICATION [IF42] | | 5460 |
| NTM DST ( ATYPICAL MYCOBACTERIUM TUBERCULOSIS DRUG SUSCEPTIBILITY) [IF21] | | 10760 |
| NTM PCR [IF3] | | 5020 |
| NTXN-TELLOPEPTIDE(COLLAGEN CROSSLINKED)URINE 24H(N0045)[MP8] | | 4350 |
| NUDT 15 MUTATION ANALYSIS[HH15] | | 5740 |
| OLIGOCLONAL BAND[MP5][O0004] | | 7500 |
| OMEGA 3 and 6 FATTY ACID[RBC10095] [OQ14] | | 9170 |
| ONCOTYPE DX SCORE [GH17] | | 399800 |
| ONE HEME FOR HEMATOLOGICAL MALIGNANCIES AND SARCOMAS-(406 GENES+RMB+MSI)[FM25] | | 480700 |
| OPPORTUNISTIC INFECTIONS PROFILE [2] | | 1380 |
| OPTHAL OPERATION THEATRE SURVEILLANCE 12 VISITS [7] | | 27940 |
| ORNITHIN – QUANTITATIVE [MP10] [O0008] | | 8090 |
| OSMOLAL GAP SERUM [LL3] | | 1530 |
| OSMOLALITY SERUM (CALCULATED) [1] | | 1180 |
| OSMOTIC FRAGILITY TEST ( RBC FRAGILITY TEST ) [MP2] | | 1260 |
| OSTEOCALCIN, SERUM(O0013)[MP2] | | 3900 |
| OSTEOPOROSIS PROFILE IV -OSTEOMOM PROFILE [MP5] | | 4290 |
| OTHER FLUID ROUTINE EXAMINATION [1] | | 2590 |
| OUTSITE-COVID-19 DETECTION BY RTPCR (SARS COV2) [IF3] | | 1160 |
| OXCARBAZEPINE[O0026][MP8] | | 6950 |
| OXIDISED LDL ANTIBODIES-IGGAND/OR IGM [O1016][MP35] | | 19280 |
| P1NP [P0001][MP4] | | 2590 |
| P53 MUTATION ANALYSIS (MULTIPLE MYELOMA,CLL-DELETION 17P) [#0031] [MP4] | | 6400 |
| P-ANCA (ANCA-PERINUCLEAR) ([MP2][M0063] | | 2010 |
| PANCREATIC ELASTASE P0139[MP9] | | 8570 |
| PANFUNGAL DETECTION and IDENTIFICATION PANEL[9602][SR5] | | 17270 |
| PAP DUO –THINPREP CYTOLOGY WITH HPV PCR(C0084)[MP5]) | | 4200 |
| PARACETAMOL / ACETAMINOPHEN (HH3] | | 7470 |
| PARACETAMOL ANTIPYRETIC [MP5] | | 1830 |
| Paraneoplastic syndrome/Neuronal Antibody Profile(N0056)[MP3] | | 19130 |
| PARASITE EXAMINATION - [1] | | 400 |
| PARASITE IDENTIFICATION [2] | | 700 |
| PARATHYROID HORMONE- INTACT (PTH-INTACT)[M,W,F][2] | | 2400 |
| PARIETAL CELL ANTIBODY [MP4][P0018] | | 3050 |
| PARVOVIRUS B19 - AMNIOTIC FLUID [RLS4] | | 3210 |
| PARVOVIRUS B19 DNA PCR [RLS4] | | 5280 |
| PARVOVIRUS B19 IGG [MP8] | | 4500 |
| PARVOVIRUS B19 IGM [MP8] | | 4460 |
| PAUL BUNNEL - INFECTIOUS MONONUCLEOSIS TEST, SERUM(P0026)[MP4] | | 1800 |
| PCR CHIMERISM - FOLLOW UP SAMPLE ( POST-TRANSPLANT PATIENT) ( P0224)[UP13] | | 7090 |
| PCR CMV QUANTITATIVE(P0040)[UP4] | | 4970 |
| PCR FOR FUNGUS IDENTIFICATION-PGI[21] | | 4300 |
| PCR PRIMARY CHIMERISM (PRE TRANSPLANT PATIENT and DONOR)( P0251)[UP15] | | 11800 |
| PD-1 [OQ21] | | 30100 |
| PDL1[NB10] | | 15400 |
| PERFORIN EXPRESSION [KEM2] | | 6330 |
| PERFORIN SOLUBLE CD25 LEVELS (PERFORIN + GRANULE RELEASE ASSAY) [ICMR-KEM4] | | 14270 |
| PERIPHERAL BLOOD CULTURE AND SENSITIVITY- BLOOD [PR1] | | 15400 |
| BORDETELLA PERTUSSIS IGG ANTIBODY - QUANTITATIVE, SERUM(B0057)[MP8] | | 3450 |
| PGT- A + PGT-M(FOR 1 EMBRYO-1VARIENT)[LI38] | | 43470 |
| PGT- A + PGT-M(FOR 2 EMBRYO-1VARIENT)[LI38] | | 69300 |
| PGT- M(FOR 1 EMBRYO[GX25] | | 11550 |
| PH TEST -WATER/FLUID [SSA2] | | 1000 |
| PHARMACOGENETICS WARFARIN [XCD20] | | 1700 |
| PHENOBARBITONE-(GARDINAL) [MP2][P0035] | | 1330 |
| PHENOL-URINE(P1017)[MP22] | | 4350 |
| PHENOTYPING MARKER IGD ( IGD BY FLOW CYTOMETRY] [MP6] | | 4240 |
| PHENOTYPING MARKER IGG ( IGG HEAVY CHAIN -SURFACE) (1675BE)[SR3] | | 4240 |
| PHENOTYPING MARKER IGM ( IGM HEAVY CHAIN -SURFACE) (1675BG)[SR3] | | 4240 |
| TDT (TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE) NUCLEAR, EDTA BLOOD(T0038)[MP3] | | 5400 |
| PHENYL KETO UREA [NG5] | | 600 |
| PHENYTOIN EPTOIN, SERUM(P0039)[MP2] | | 1400 |
| PHOSPHORUS.[1] | | 500 |
| PIK3 CA [LI7] | | 28570 |
| PLA2 RECEPTOR ANTIBODY - QUALITATIVE, SERUM(P0060)[MP7] | | 6000 |
| PLACENTA GROWTH FACTOR [LI4] | | 3860 |
| PLASMA HAEMOGLOBIN [MP7][H0003] | | 1440 |
| PLASMA PIPECOLIC ACID ANALYSIS[NL8] | | 10030 |
| PLASMALOGENS IN RBC [NL13] | | 4640 |
| PLATE SLANT FOR IDENTIFICATION [3] | | 1200 |
| PLATELET ANTIBODIES QUALITATIVE TEST [P0062][MP8] | | 11630 |
| PLATELET COUNT[1] | | 400 |
| PLATELET COUNT BY MANUAL METHOD[1] | | 500 |
| PLATELET FACTOR 4 (PF4) ANTIBODY [MB3] | | 8970 |
| PLATELET FUNCTION TEST[MBA5] | | 11800 |
| PLATELET MAPPING ASSAY [1] | | 12930 |
| PLATELET RICH FIBRIN - CONSUMABLES[1] | | 1900 |
| PLEURAL FLUID ROUTINE EXAMINATION[1] | | 2590 |
| PML RARA T(15;17) - QUANTITATIVE BY PCR, EDTA BLOOD**(T0014)[MP8] | | 6800 |
| PMP22 DNA SEQUENCING TEST -SINGLE GENE [SL35] | | 18290 |
| PNEUMOCYSTIS CARINII DETECTION [IF2] | | 5100 |
| PNEUMOCYSTIS JIROVECII BY RT PCR [IF3] | | 8610 |
| PNEUMONIA PANEL BY FILM ARRAY BIOFIRE [LI2] | | 37310 |
| PNH ( PAROXYSMAL NOCTURNAL HEMOGLOBINURIA) BY FLOW CYTOMETRY [SL2] | | 9260 |
| POLE MUTATION STUDY[NB15] | | 19400 |
| POLIOVIRUS TYPES 1-3 ANTIBODIES [SR25] | | 37970 |
| PORPHYRIA PROFILE, URINE SPOT [MP8] | | 7100 |
| POST GLUCOSE BLOOD SUGAR ( PGBS )[1] | | 450 |
| POTASSIUM[1] | | 450 |
| PR3 C-ANCA and MPO BY EIA -P-ANCA [MP2][A0512] | | 3230 |
| HLA-PRA(Panel Reactive Antibody) Screening (Class I and II) by Luminex(H0801)[MP2] | | 8500 |
| Pre Albumin, Serum(P0083)[MP2] | | 4400 |
| PRECIPITIN SCREEING TEST [MP31] | | 7890 |
| PRE-ECLAMPSIA TEST[LI5] | | 3110 |
| SICKLE CELL ANEMIA/HBE/HBD MUTATION ANALYSIS (PARENTS + FETUS/INDEX CHILD) [LI10] | | 12900 |
| PRENATAL SANGER VARIENT ANALYSIS- 2 VARIANTS [1484][MG30] | | 59550 |
| PRE-PGT -2 INDIVIDUALS(1 VARIENT)[LI22] | | 11550 |
| PRO-CALCITONIN [1] | | 3620 |
| PROGESTERONE | | 1470 |
| PROLACTIN - POOLED SAMPLE[M,W,F][2] | | 1600 |
| PROLACTIN[M,W,F][2] | | 1000 |
| PROSIGNA TEST - BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY[OC22] | | 95420 |
| PROTEIN C ACTIVITY FUNCTIONAL, CITRATED PLASMA(P0094)[MP5] | | 5460 |
| PROTEIN C ANTIGEN [MP2][P0095] | | 6170 |
| PROTEIN ELECTROPHORESIS - SERUM [MP2][P0096] | | 1370 |
| PROTEIN S ACTIVITY FUNCTIONAL, CITRATED PLASMA(P00990[MP5] | | 5500 |
| PROTEIN S ANTIGEN (FREE) [MP5][P0100] | | 7620 |
| PROTHROMBIN TIME[1] | | 540 |
| PRP LAB PROCESSING *1 [1] | | 2000 |
| PRP LAB PROCESSING *4 [1] | | 7950 |
| PRP LAB PROCESSING *6 [1] | | 11930 |
| PRP LAB PROCESSING 2T [1] | | 2250 |
| PRP PROCESSING STERILE [HANDOVER TO DERMO AFTER CENTRIFUGATION][1] | | 450 |
| PRUSSIAN BLUE STAIN ON HISTOCHEMISTRY, TISSUE [MP4] | | 1800 |
| PSA (PROSTATE SPECIFIC ANTIGEN)[1] | | 1530 |
| PSA + FREE PSA + RATIO[1] | | 2280 |
| PSEUDO CHOLINESTERASE OPC POISONING (P0113)[MP2] | | 1870 |
| PTH - RP -PARATHORMONE RELATED PROTEIN-P1055 [MP35] | | 22350 |
| PUO MULTIPLEX [IF2] | | 21530 |
| PUO PROFILE [MP6][P0115] | | 6460 |
| PYRUVATE - BLOOD ( PYRUVIC ACID)( BY PRIOR APPONTMENT) [P0117] [MP4] | | 3230 |
| PYRUVATE - CSF ( PYRUVIC ACID)( BY PRIOR APPONTMENT) [HH2] | | 3700 |
| QUADRUPLE MARKER TEST [LI5] | | 3740 |
| RA FLUID TEST( RHEUMATOID ARTHRITIS FROM FLUID)[MP2][R0002] | | 900 |
| RA TEST ( RHEUMATOID ARTHRITIS )[1] | | 690 |
| RABIES ANTIBODIES [MP8][R0004] | | 5110 |
| RAPID MP (RAPID TEST MALARIAL PARASITES) MALARIA ANTIGEN[1] | | 780 |
| RAPID TYPHOID TEST [1] | | 870 |
| REDUCING SUBSTANCES -OTHER[1] | | 200 |
| REFLEX PLOIDY AND PROGNOSTIC TUBE [SL2] | | 7900 |
| DIALYSIS PROFILE (ADP)[1] | | 1900 |
| RENAL PROFILE BIOCHEM[1] | | 2340 |
| RENIN ACTIVITY, PLASMA (RPA) [MP5][P0082] | | 6800 |
| RENIN DIRECT -PLASMA [MP2][R0013] | | 4660 |
| RESPIRATORY BACTERIAL MULTIPLEX [IF2] | | 8610 |
| RESPIRATORY PANEL [MP2][R0066] | | 21120 |
| RESPIRATORY PANEL FOR IMMUNOSUPPRESSED INDIVIDUAL [IG2] | | 28550 |
| RESPIRATORY SYNCYTIAL VIRUS IGG [MP7] | | 2720 |
| RESPIRATORY SYNCYTIAL VIRUS IGM [MP7] | | 2720 |
| RESPIRATORY VIRAL MULTIPLEX [IF2] | | 11500 |
| RET GENE MUTATIONS [MP21][ R0058] | | 3860 |
| RETICULOCYTE COUNT[1] | | 350 |
| REVERSE T3 [LL3-7WEEK] | | 24560 |
| RH ANTIBODY TITRE [1] | | 780 |
| RIFAMPICIN DRUG LEVEL [HH7] | | 6300 |
| RISTOCETIN COFACTOR ACTIVITY [MB2] | | 7900 |
| RLBH DRUG SENSITIVITY TO RIFAMPICIN and INH [HH43] | | 4700 |
| RLBH MYCOBACTERIA IDENTIFICATION [HH43] | | 4700 |
| RO WATER ENDOTOXIN TEST(0.25) [SS11] | | 5000 |
| ROS1 (LUNG CANCER) [PR8] | | 4600 |
| ROTA VIRUS-STOOL[1] | | 700 |
| BCR-ABL1 RT-QPCR FOR P210(IS)&/OR P190[LI7] | | 14400 |
| RUBELLA ( GERMAN MEASLES ) IGG [1] | | 1840 |
| RUBELLA ( GERMAN MEASLES ) IGM [1] | | 1250 |
| RUBELLA (GERMAN MEASLES) VIRUS RNA DETECTION BY PCR [MP3][R0050] | | 4260 |
| RUBELLA IGG AVIDITY/ RUBELLA (GERMAN MEASLES) VIRUS AVIDITY TEST [R0044 ][MP3] | | 1680 |
| SAAG [ SERUM-ASCITES ALBUMIN GRADIENT ] REPORTING FROM FLUID-SERUM[1] | | 770 |
| SALIVA SCREEN FOR ALCOHOL[1] | | 700 |
| SALIVARY CORTISOL [HH7] | | 2150 |
| SAMPLE FOR NA AND K [1] | | 910 |
| SARS COV-2 NUCLEOCAPSID ANTIBODY QUALITATIVE(NOT FOR VACCINATED) [MP3] | | 1010 |
| SARS -COV-2(SPIKE) ANTIBODY ,QUANTITATIVE (MP2] | | 1700 |
| SARS-COV-2 (COVID-19) RT PCR (GENXPERT) [1] | | 5000 |
| SCA COMPREHENSIVE PANEL (1,2,3,6,7,10 and 12 TYPES) [MP5] | | 20800 |
| SCA12 SPINOCEREBELLAR ATAXIA TYPE 12 CAG REPEATS [MP10][S0007] | | 4070 |
| SCHISTOSOMIASIS - CONFIRMATION SEROLOGY – SERUM [MP35] | | 12390 |
| SCL 70 ANTIBODY [MP4][S0008] | | 2170 |
| Scl-70 Antibody, Serum(S0008)[MP3] | | 2400 |
| SCLERODERMA PROFILE [MP5][S0009] | | 6780 |
| SCRUB TYPHUS IGM[S0071][MP3] | | 1480 |
| SCRUB TYPHUS PROFILE (WEIL FELIX AND SCRUB TYPHUS IGM) [MP5] | | 1430 |
| SELENIUM, SERUM(S001)[MP5] | | 6000 |
| ACID PHOSPHATASE TOTAL, SERUM(A0013)[MP2] | | 800 |
| SEMEN ACROSOME INTACTNESS REACTION [PR2] | | 920 |
| SEMEN ANALYSIS[2] | | 600 |
| SEMEN KRUGGERS TEST (DETAILED SPERM MORPHOLOGY) [2] | | 1180 |
| SEPTISCREEN - COMPREHENSIVE PANEL-MPN009 [IG2] | | 20090 |
| SEROTONIN, SERUM(S0016)[MP8] | | 6000 |
| SERUM BETA D GLUCAN [HH7] | | 4640 |
| SERUM BETA D GLUCAN [IF2] | | 10760 |
| SERUM COLLECTION - STAT TRANSPORT[1] | | 300 |
| SERUM IMMUNOFIXATION ELECTROPHORESIS QUANTITATIVE(I0262) | | 9800 |
| SERUM METHYL MALONIC ACID QUANTITATIVE [MP8][M0141] | | 4260 |
| MYOGLOBIN, SERUM(M0091)[MP2] | | 3330 |
| SERUM SOLUBLE TRANSFERRIN RECEPTOR [MP4] [S0036] | | 1940 |
| SES MENINGITIS PROFILE [XC4] | | 23150 |
| SES RESPIRATORY VIRAL PANEL [XC3] | | 49360 |
| SEX HORMONE BINDING GLOBULIN ( SHBG ) [PR2][3218] | | 2740 |
| EVICO PE-PRO (SFLT-1/PLGF RATIO) [LI5] | | 6900 |
| SICKLE CELL ANAEMIA MUTATION ANALYSIS [LI8] | | 2870 |
| SICKLE CELL ANEMIA /HBE/HBD (ONE PARENT)+ B-THALASSEMIA SEQUENCING(OTHER PARENT)+PND FOR FETUS[LI15] | | 10500 |
| SICKLING TEST [2] | | 400 |
| SIROLIMUS[MP5][S0026] | | 7110 |
| SJOGRENS SYNDROME PROFILE[MP8] | | 3730 |
| SKELETAL DYSPLASIA PANEL [LI15] | | 35880 |
| SMA MLPA [SL22] | | 12100 |
| SMEAR FOR NOCARDIA[1] | | 900 |
| SMITH (SM) ANTIBODY, SERUM [MP5][S0030] | | 2200 |
| SODIUM - BREAST MILK[1] | | 350 |
| SODIUM ( NA )[1] | | 350 |
| SOLUBLE CD25 (IL2 RECEPTOR)[MP9] | | 12420 |
| SOLUBLE LIVER ANTIGEN (SLA) [MP2][S0028] | | 4000 |
| SOMATIC MUTATION TESTING FOR BRCA1-BRCA2[SL35] | | 34800 |
| SPASTIC PARAPLEGIA [NMDT008] [SL35-42] | | 43040 |
| SPECIAL ANTIMICROBIAL SUSCEPTIBILITY TEST [2] | | 1000 |
| SPECTRAL KARYOTYPE[LI15] | | 26300 |
| SPERM DNA FRAGMENTATION (DFI), SEMEN(S0077_SPERM-DFI)[MP4] | | 6400 |
| SPERM FUNCTION TEST [PR3] | | 4020 |
| SPINAL MUSCULAR ATROPHY SEQUENCING[LI30] | | 23100 |
| SPINOCEREBELLAR ATAXIA REPEAT EXPANSION ANALYSIS SCA1-2-3-6-7-12[MG21] | | 22960 |
| SPUTUM ROUTINE and MICROSCOPIC EXAMINATION [1] | | 800 |
| FISH-SRY[LI18] | | 10000 |
| SSA RO ( SOLUBLE SUBSTANCE A ) ANTIBODY [MP5] | | 3700 |
| SSB (SOLUBLE SUBSTANCE B) / LA ANTIBODY ( [MP5] | | 3700 |
| STD BASIC PROFILE-[S0048][MP6] | | 4470 |
| STEROIDS PANLE[TC2] | | 4020 |
| STI SCREENING MULTIPLEX -13 TARGETS [IF2] | | 9930 |
| STONE ANALYSIS[SR5] | | 2150 |
| STOOL CALPROTECTIN(C0031)[MP2] | | 3850 |
| STOOL CRYPTOSPORIDIUM ANTIGEN DETECTION [MP2][C0180] | | 2070 |
| STOOL FAT GLOBULES [1] | | 170 |
| STOOL HANGING DROP [1] | | 870 |
| STOOL HELICOBACTER PYLORI ANTIGEN DETECTION[MP2][H0063] | | 1940 |
| STOOL OCCULT BLOOD[1] | | 210 |
| STOOL PH[1] | | 170 |
| STOOL REDUCING SUBSTANCES[1] | | 170 |
| STOOL ROUTINE[1] | | 220 |
| STREP PNEUMONIAE ANTIGEN - [HH2] | | 3400 |
| STRESS CYTOGENETICS [LI10] | | 15780 |
| STRONGYLOIDIASIS- SERUM [MP35][S1020] | | 7430 |
| SUCROSE LYSIS TEST (PNH SCREENING TESTS)(S0063)[MP3] | | 1330 |
| SURE T- NON INVASIVE CHROMOSOME SCREENING-PGT-SPENT MEDIA 3 EMBRYO[LI15] | | 55880 |
| SURE.T- NON INVASIVE CHROMOSOME SCREENING-PGT-SPENT MEDIA –4 EMBRYO[LI15] | | 67050 |
| SURET- NON INVASIVE CHROMOSOME SCREENING-PGT-SPENT MEDIA –1 EMBRYO[LI5] | | 22350 |
| SURET NON INVASIVE CHROMOSOME SCREENING-PGT-SPENT MEDIA –2 EMBRYO[LI15] | | 39730 |
| SURET.- NON INVASIVE CHROMOSOME SCREENING-PGT-SPENT MEDIA –5 EMBRYO[LI15] | | 74500 |
| SURVEILLANCE TESTING- EXTERNAL[3] | | 4300 |
| SURVEILLANCE TESTING- INTERNAL[3] | | 0 |
| SYPHILLIS ANTIBODEIS (TOTAL) TREPONEMA BY EIA[S0067][MP4] | | 1700 |
| T CELL RECEPTOR CLONALITY ASSAY [SR10] | | 41600 |
| T790M LIQUID BIOPSY [LI10] | | 30120 |
| TACROLIMUS [MP2][T0032] | | 5430 |
| TANDOM MASS PANEL TMS [NG3] | | 5020 |
| TB CULTURE MGIT and IDENTIFICATION- OTHER FLUIDS [HH42] | | 2500 |
| TB CULTURE MGIT and IDENTIFICATION -SPUTUM [IF42] | | 3500 |
| TB DRUG SUSCEPTIBILITY(10DR) BY MGIT–TB015(SIREP-KEPO-CAPREO) [IF21] | | 12000 |
| TB DRUG SUSCEPTIBILITY(13DR) BY MGIT–TB016(SIREP-KEPO-MACC) [IF21] | | 16700 |
| TB DRUG SUSCEPTIBILITY(15DR) BY MGIT-TB017(IREP-KEPO-MACC-LEVO-LZ-MOX[IF21] | | 19400 |
| TB GOLD (QUANTIFERON) ( GAMMA INTEFERON FOR TB)[I0373][MP4] | | 3700 |
| TB LPA MOLECULAR SECOND LINE- FLUOROQ-AMINOGLY-ETHAMB[HH3] | | 4600 |
| TB MGIT DST MOXIFLOXACIN [IF21] | | 2100 |
| TB PCR QUALITATIVE BY MYCOREAL [IF2] | | 3200 |
| TB PCR WITH HYBRIDISATION [HH12] | | 4800 |
| TB PYROSEQUENCING MDR + XDR [HH7] | | 9300 |
| T-CELL PROLIFERATION STAT-1 AND STAT-3[KH-NI15] | | 630 |
| TEG (THROMBOELASTOGRAPH) [1] | | 9310 |
| TESTOSTERONE [1] | | 1470 |
| TESTOSTERONE PROFILE [T0043][MP3] | | 4530 |
| TETANUS TOXIC IGG QUANTITATIVE BY EIA[MP8] | | 6030 |
| TH- COVID-19 DETECTION BY RTPCR (SARS COV2) [IF3] | | 860 |
| THALLIUM [MP6] [T0046] | | 4020 |
| THEOPHYLLINE, SERUM(T0049)[MP2] | | 1400 |
| THROMBIN TIME[1] | | 870 |
| THROMBOCHECK TOTAL[SR7] | | 28600 |
| THROMBOTIC PROFILE[MP5][T0056] | | 21710 |
| THROMBOTIC RISK DNA PANEL [MP11] | | 15780 |
| THYROGLOBULIN [PR2] | | 1870 |
| THYROID PROFILE - T3, T4 AND TSH[1] | | 1750 |
| TISSUE COPPER ESTIMATION [KH2] | | 5700 |
| TISSUE TRANSGLUTAMINASE (TTG) ANTIBODY - IGA (T0133) [MP2] | | 2000 |
| TISSUE TRANSGLUTAMINASE (TTG) ANTIBODY - IGG [MP5][T0134] | | 2010 |
| TNF ALPHA TUMOUR NECROSIS FACTOR [T0071] [MP13] | | 6030 |
| TOPIRAMATE [MP35] | | 31470 |
| TORCH AMNIOTIC FLUID[LI10] | | 8700 |
| TORCH IGG and IGM ANTIBODIES EVALUATION (10 PARAMETERS) [MP2][T0077] | | 4140 |
| TORCH PCR (TOXOPLASMA PCR, RUBELLA PCR, | | 6600 |
| TOTAL CHOLESTEROL.[1] | | 350 |
| TOTAL PROTEIN[1] | | 580 |
| TOTAL T3 (TRIIODOTHYRODINE)[1] | | 680 |
| TOTAL T4 (THYROXINE)[1] | | 680 |
| TOXIC ELEMENT PANEL/HEAVY METALS [TC3] | | 3260 |
| TOXOPLASMA AVIDITY, SERUM(T0086)[MP5] | | 2600 |
| TOXOPLASMA DNA DETECTION [BLOOD] BY PCR [MP5] | | 4640 |
| TOXOPLASMA DNA DETECTION BY PCR CSF[T0091][MP4] | | 4260 |
| TOXOPLASMA GONDII PCR(7522) [SR5] | | 3990 |
| TOXOPLASMA IGG [MP2][T0094] | | 1040 |
| TOXOPLASMA IGM [MP2][T0096] | | 990 |
| TOXOPLASMA-IGG ANTIBODY CSF[MP3] | | 4260 |
| TPHA (TREPONEMA PALLIDIUM HAEMAGGLUTINATION ASSAY) [MP3] | | 810 |
| TPMT ENZYME ACTIVITY THIOPURINE METHYL TRANSFERASE[T0098][MP4] | | 6060 |
| TPMT (THIOPURINE S-METHYLTRANSFERASE) GENOTYPE, EDTA BLOOD(T0099)[MP7] | | 7300 |
| TPMT MUTATION ANALYSIS [HH15] | | 11490 |
| TRANSFERRIN LEVEL-SERUM [M,W,F][2] | | 2300 |
| TRICYCLIC ANTIDEPRESSANTS DUG (TCA) QUALITATIVE- URINE[MP2][T0987] | | 860 |
| TRIGLYCERIDES.[1] | | 400 |
| TRIPLE MARKER TEST[LI5] | | 3110 |
| TROPONIN-I (HIGH SENSITIVE)[1] | | 2130 |
| TRYPANOSOMA CRUZI IGG [MP15][T0145] | | 2940 |
| TSH (ULTRASENSITIVE)[1] | | 970 |
| TSH RECEPTOR IGG ANTIBODY(T0131)[MP2] | | 5700 |
| TUMOR MUTATION BURDEN METHODOLOGY MOLECULAR NGS -MARKER MTB [LI25] | | 54500 |
| TUMORINSIGHT WITHOUT TMB [DL8] | | 58400 |
| TZANCK SMEAR[1] | | 400 |
| U1-SNRNP(68 KDA) [MP5][U0001] | | 2130 |
| UGT1A1 GENE POLYMORPHISM[MP5][U0003] | | 8160 |
| URIC ACID[1] | | 400 |
| URINE MYOGLOBULIN [MP2][M0092] | | 1550 |
| URINE 10 DRUG OF ABUSE PANEL[1] | | 5690 |
| URINE 5 DRUG OF ABUSE PANEL[1] | | 4360 |
| URINE ACETONE/ KETONE (QUALITATIVE) [1] | | 160 |
| URINE ADRENALINE(EPINEPHRINE) [A0042][MP8] | | 4080 |
| URINE ALCOHOL(ETHANOL) [MP2][A0129] | | 1300 |
| URINE AMINO ACIDS [MP8] | | 1610 |
| URINE AMINO LEVULINIC ACID [MP9][A0425] | | 5580 |
| URINE AMPHETAMINE [1] | | 970 |
| URINE BARBITURATE[1] | | 1340 |
| URINE BENCE JONES PROTEIN [MP2][B0013] | | 1430 |
| URINE BENZODIAZAPINE [1] | | 870 |
| URINE BICARBONATE [HH3] | | 740 |
| URINE BILE SALTS and BILE PIGMENTS [1] | | 170 |
| URINE CALCIUM / CREATININE RATIO[1] | | 910 |
| URINE CALCIUM [1] | | 450 |
| URINE CHLORIDE [1] | | 540 |
| URINE CHYLOMICRONS QUALITATIVE [C0115][MP2] | | 680 |
| URINE CHYLURIA [MP2] | | 690 |
| URINE COCAINE [1] | | 970 |
| SPOT URINE COPPER[C0155][MP5] | | 2900 |
| URINE CORTISOL [MP2][C0158] | | 1220 |
| URINE CREATININE [1] | | 400 |
| URINE CYSTINE (C0223) [MP11] | | 8090 |
| URINE DNPH (DI-NITRO PHENYEL HYDRALAZINE [MP2] | | 460 |
| URINE DYSMORPHIC RBC DETECTION(D0049) [MP2] | | 200 |
| URINE ECSTASY ( XTC) MDMA [1] | | 970 |
| URINE ELECTROLYTES (NA, K, CL) | | 990 |
| URINE FAT GLOBULES [1] | | 160 |
| URINE FERRIC CHLORIDE TEST [MP2][F0017] | | 450 |
| URINE FREE CORTISOL[MP2][C0158] | | 1220 |
| URINE FREE HAEMOGLOBIN [MP3] | | 640 |
| URINE FREE LIGHT CHAIN ASSAY [KAPPA and LAMBDA][K0001] [MP2] | | 6580 |
| URINE GLUCOSE [1] | | 500 |
| URINE HAEMOSIDERIN [MP4] | | 2770 |
| URINE HOMOGENISTIC ACID(H0256)[MP2] | | 1100 |
| URINE IMMUNOFIXATION ELECTROPHORESIS QUANTITATIVE [MP4] | | 13190 |
| URINE LEGIONELLA PNEUMOPHILA ANTIGEN [HH2] | | 5260 |
| URINE MAGNESSIUM [1] | | 870 |
| URINE MARIJUANA/ CANNABIS/ THC [1] | | 970 |
| URINE MERCURY [9138U] SR8] | | 3990 |
| URINE METHADONE [1] | | 970 |
| URINE METHAMPHETAMINE [1] | | 970 |
| URINE DRUG FOR METHAQUALONE[MP2 | | 1100 |
| URINE METHYL MALONIC ACID QUALITATIVE [MP6][M0048] | | 910 |
| URINE MICROALBUMIN (ALBUMIN) / URINARY CREATININE RATIO (M,W,F | | 1400 |
| URINE MICROALBUMIN(6-4)(6-4)[M,W,F][2] | | 1300 |
| URINE MPS - GAG QUANTITATION, EPP AND OLIGOSACCHARIDES [NL6] | | 11600 |
| URINE MUCOPOLYSACCHRIDES SCREEN [MP2][M0074] | | 740 |
| URINE NICOTINE METABOLITE [MP2][N0022] | | 2080 |
| URINE OPIATES/ MORPHINE [1] | | 970 |
| URINE ORGANIC ACID SCREEN [3966] [SR12] | | 8770 |
| URINE ORGANIC ACID TESTING[NG5] | | 6170 |
| URINE OSMOLALITY [O0011][MP2] | | 1400 |
| URINE OXALATE [MP3] | | 3210 |
| URINE OXYCODONE[1] | | 1070 |
| URINE PH [1] | | 150 |
| URINE PHENCYCLIDINE/ PCP [1] | | 970 |
| URINE PHOSPHORUS [1] | | 610 |
| URINE PORPHOBILINOGEN QUANTITATIVE RANDOM(P0125) [MP8] | | 4910 |
| URINE PORPHOBILINOGEN SCREEN-QUALITATIVE-3SAMPLES[HH2] | | 1490 |
| URINE POTASSIUM [1] | | 450 |
| URINE PREGNANCY TEST[1] | | 1070 |
| URINE PROPOXYPHENE [1] | | 2490 |
| URINE PROTEIN (ALBUMIN) -QUALITATIVE [1] | | 170 |
| PROTEIN ELECTROPHORESIS, URINE 24 HRS(P0097) | | 1200 |
| URINE PROTEIN QUANTITATIVE [1] | | 970 |
| URINE REDUCING SUBSTANCES [1] | | 170 |
| URINE ROUTINE[1] | | 320 |
| URINE SODIUM [1] | | 400 |
| URINE SPECIFIC GRAVITY [1] | | 170 |
| URINE -SPOT PORPHOBILINOGEN QUANTITATIVE [MP8][P0125] | | 5040 |
| URINE SUGAR and URINARY KETONE (QUALITATIVE) [1] | | 170 |
| URINE UREA NITROGEN [1] | | 400 |
| URINE URIC ACID [1] | | 430 |
| Valproic Acid (Sodium Valporate)( V0001)[MP2] | | 1400 |
| VANCOMYCIN [HH2] | | 9260 |
| VARICELLA (HERPES) ZOSTER - IGG ANTIBODIES[MP2 ] [V0029] | | 4840 |
| VARICELLA (HERPES) ZOSTER - IGM ANTIBODIES[MP2][V0030] | | 4840 |
| VASCULITIS PANEL MP4][V0148] | | 5800 |
| VASOACTIVE INTESTINAL POLYPEPTIDE VIP [SR25][8150] | | 25730 |
| VDRL - CSF [MP2] | | 550 |
| VDRL ( RAPID PLASMA REAGIN - RPR)[M,W,F][2] | | 500 |
| VERY LONG CHAIN FATTY ACIDS (VLCFA) [NL][13] | | 15420 |
| VGCC (VOLTAGE GATED CALCIUM CHANNEL) [V0005]MP50] | | 13280 |
| VGKC - VOLTAGE GATED POTASSIUM CHANNEL [MP10] | | 12850 |
| VIRAL CNS PANEL [IG3] | | 29320 |
| VIRAL CNS PANEL -ANY8 [IG2] | | 13890 |
| VIRAL MARKERS(SCOPY)-LAB[1] | | 1300 |
| VITAMIN A (RETINOL) - QUANTITATIVE, SERUM(V0008)[MP5] | | 5300 |
| VITAMIN B1 (THIAMINE)[MP5][V0009] | | 4610 |
| VITAMIN B12 (CYANOCOBALAMIN)[1] | | 1870 |
| VITAMIN B3 (NIACIN) - QUANTITATIVE, SERUM(V8123)[MP9] | | 20800 |
| VITAMIN B6 (PYRIDOXINE)[MP9][V0013] | | 4350 |
| VITAMIN D (25 HYDROXY )[1] | | 3050 |
| VITAMIN E (TOCOPHEROL) [MP4][V00518] | | 6170 |
| VITAMIN K1, SERUM[MP15][V0037] | | 6200 |
| VLCFA [SH25] | | 17830 |
| VON WILLEBRAND FACTOR ANTIGEN, PLASMA [MB2] | | 7900 |
| VW-VON WILLEBRAND ANTIGEN, CITRATED PLASMA(V0022)(MP8] | | 17300 |
| VORICONAZOLE [MP5][V0032] | | 7500 |
| VZV VARICELLA ZOSTER VIRUS DNA DETECTION BY PCR CSF[MP5](V0025) | | 4260 |
| WATER ANALYSIS CHEMICAL [MP8] | | 3200 |
| WATER MICROBIOLOGICAL CULTURE | | 1200 |
| WEIL FELIX TEST FOR RICKETTSIA, SERUM(W0010)[MP3] | | 1500 |
| WHOLE EXOME SEQUENCING[LI42] | | 31500 |
| WIDAL TEST[2] | | 500 |
| WILLIAMS SYNDROME (DELETION 7Q11.23) BY FISH [MP8] | | 12340 |
| WILSON DISEASE (ATP7B) GENE ANALYSIS, NGS (G0158)[MP30] | | 24200 |
| WISDOM GENETIC ANALYSIS PLAN [DL18] | | 101810 |
| Y-CHROMOSOME MICRODELETION ANALYSIS, EDTA BLOOD(Y0001)[MP10] | | 11300 |
| ZIKA VIRUS [Z0011] [MP3] | | 8570 |
| ZINC ESTIMATION [MP3] | | 2890 |
| PAP'S SMEAR[2] | | 500 |
| NEONATAL METABOLIC SCREEING PACKAGE[NG5] | | 6200 |
| GERMLINE BRCA1 and BRCA2 [SL21] | | 18010 |
| BONE MARROW BIOPSY INTERPRETATION-SMEAR EXAMINATION-COVENTIONAL KARYOTYPING[UP10] | | 10560 |
| BIOPSY (BONE MARROW) INTERPRETATION WITH SMEAR EXMAINATION [UP15] | | 3980 |
| PD IIT B STUDY | | 300 |
| IDH 1/2 Mutation Detection [TH20] | | 28300 |
| PNEUMOCYSTIS JIROVECII DETECTION-QUANTITATIVE [IF2] | | 8090 |
| ACTH Stimulation Tests for Androstenedione [MP3] [ | | 5410 |
| Next Generation Sequencing (NGS) Advance -Onco haem Plus SNV/Indels (DNA) [SL18] | | 17330 |
| IGD (IMMUNOGLOBULIN D) [PR25][9272] | | 15590 |
| Reassure BOH Maxi [R5589][MP15] | | 13470 |
| GENOME SEQUENCING FOR SEPSIS PATHOGENS [HS2) | | 10400 |
| RESPIRATORY PANEL BY QIAstat-Dx [1] | | 11000 |
| GASTROINTESTINAL PANEL by QIAstat-Dx[1] | | 13900 |
| MENINGITIS/ENCEPHALITIS PANEL by QIAstat-Dx [1] | | 13860 |
| CBC EXPERT[SL1] | | 1250 |
| FLUID CREATININE[1] | | 530 |
| ALLERGY PANEL - MILK & MILK PRODUCTS(A0362)[MP3] | | 5200 |
| ALLERGEN CASEIN -MILK PROTEIN -DAHI [MP3] | | 1730 |
| FLUID LIPASE [1] | | 1100 |
| FLUID BILIRUBIN [1] | | 400 |
| FLUID TOTAL CHOLESTEROL [1] | | 300 |
| FLUID TRIGLYCERIDES [1] | | 400 |
| FROZEN SECTION - URGENT SAMPLE WAITING TIME CHARGES[1] | | 3500 |
| AEROBIC CULTURE and SENSITIVTY-STOOL[3] | | 2100 |
| AEROBIC CULTURE-Lower Respiratory-Bal, ETsecretion,Lung Biopsy, TT,EBUS TNA,EBUS lymphnode[3] | | 2100 |
| AEROBIC CULTURE and SENSITIVITY-BODY FLUIDS[3] | | 2100 |
| AEROBIC CULTURE and SENSITIVITY-PUS/SWABS/TISSUE[3] | | 2100 |
| HISTOPATHOLOGY ON CELL BLOCK[10] | | 1500 |
| HISTOPATH SECOND OPINION [PR10] | | 16200 |
| CYTOLOGY EXAMINATION > 15 SLIDES[2] | | 2890 |
| I-STAT CARDIAC TROPONIN I (CTNI)[1] | | 2070 |
| Antibody screening (Class I and Class II) [AC7] | | 57750 |
| KIR Typing [ACT7] | | 13280 |
| AFST Broth Micro Dilution for Fungal susceptibility mold [HH5] | | 1700 |
| FISH IGH GENE REARRANGEMENT fo162[UP8] | | 7500 |
| KIDNEY BIOPSY LIGHT MICROSCOPY[CD6] | | 5800 |
| KIDNEY BIOPSY - ELECTRON MICROSCOPY [CD22] | | 15000 |
| KIDNEY BIOPSY – IMMUNOFLUORESCENCE [CD6] | | 5800 |
| LCMS-MS 13 STEROID PANEL(8-10am OR 4-6pm) [LL5] | | 5200 |
| MATURITY-ONSET DIABETES OF THE YOUNG (MODY)[MG21] | | 16170 |
| DRUG PANEL - ANTIBIOTICS 19 DRUGS-SERUM(D8267)[MP6] | | 13280 |
| DRUG PANEL – COMPREHENSIVE 35 DRUGS-SERUM(D8266)[MP6] | | 20790 |
| ALLERGY PANEL COMPREHENSIVE (A5702)[MP2] | | 19060 |
| FNAC PROCEDURE [1] | | 1700 |
| URINE POTASSIUM / CREATININE RATIO[1] | | 910 |
| AUTOIMMUNE ATYPICAL PARKINSONISM PANEL + HOMER 3 [ZLS7] | | 48460 |
| DNA ANALYSIS FOR HEMOGLOBINOPATHY[MG14] | | 23600 |
| INVASIVE FUNGAL SEPSIS MULTIPLEX [PC154] [IF2] | | 17330 |
| CHITOTRIOSIDASE STORAGE DISORDER (C0090)[MP15] | | 4850 |
| TB TARGETED NGS PANEL [HZ15] | | 10400 |
| MYELOMA WORKUP BASIC PANEL[UP6] | | 9310 |
| STREPTOCOCCUS PNEUMONIAE ANTIGEN DETECTION, URINE(S0062)[MP2] | | 1700 |
| 24 HOUR URINE GLUCOSE[1] | | 690 |
| URINE MAGNESIUM/ CREATININE RATIO[1] | | 1220 |
| SCA2 SPINOCEREBELLAR ATAXIS TYPE 2 REPEATS[MP5] | | 3810 |
| SEPSIS WITH AMR MULTIPLEX [IF2] | | 20790 |
| HLA - SINGLE ANTIGEN BEAD ASSAY (CLASS I & II) BY BEAD BASED IMMNUNOASSAY - LUMINEX(H0233][MP3] | | 49900 |
| HLA High Resolution Typing (A, B, C, DR, DQ, DP) - BMT/ Stem cell Transplant Gene Panel NGS[MP10] | | 17300 |
| NGS UNIEXOME SOLO WholeExome +MtDNA+CNV) NGS045[UP30] | | 34650 |
| HLA DQ ALPHA AND BETA INDIVIDUAL (BOH) [LI21] | | 13860 |
| CDC/HLA Cross Match H0235 [MP3] | | 3070 |
| HLA - T & B Cell Cross Match, Heparin Blood and Serum H0862[MP5] | | 8200 |
| HLA Donor Specific Antibody (DSA)by Bead Based Immnunoassay H0214[MP3] | | 12990 |
| PRA identification Class I and Class II H0867[MP3] | | 22040 |
| URINE PROTEIN (UPRO) / URINARY CREATININE RATIO [2] | | 1590 |
| HOME CARE VISIT CHARGES [1] | | 200 |
| LSSA + NBT DHR [ICMR-NIIH-7] | | 4040 |
| PRIMARY IMMUNODEFICIENCY (PID) ADVANCE PANEL [SL3] | | 20210 |
| NGS Blood – Infection Test Using NGS[HS2] | | 9240 |
| Aspergillus DNA detection by RT-PCR (A0656) [MP4] | | 9560 |
| I-STAT PT INR [1] | | 920 |
| VITAMIN B7 -BIOTIN [MP2] | | 4410 |
| HISTOPATH BIOPSY SMALL [UP6] | | 1700 |
| IMMUNOHISTOCHEMISTRY (IHC) EXTENDED PANEL [UP8] | | 8100 |
| Comprehensive Coverage of Bacterial and Fungal Pathogens -Urine NGS [HS2] | | 11550 |
| HRD - HOMOLOGOUS RECOMBINATION DEFICIENCY BLOOD -t1130 [NB30] | | 109730 |
| ANTI COMPLEMENT FACTOR H [MP2] | | 6180 |
| TACROLIMUS GENOTYPING (CYP3A5) [MP14] | | 9700 |
| BETA 2 MICROGLOBIN URINE [MP2] | | 2350 |
| KARDIOGEN PANEL [MG21] | | 16170 |
| NGS ONCOMINE MYELOID V2GX ASSAY -NGS001 [UP12] | | 23100 |
| MUCOR PCR [HH15] | | 2310 |
| ASPERGILLUS PCR [IF2] | | 5900 |
| NTM PCR [HH15] | | 3700 |
| NTM CULTURE[HH21-42] | | 2400 |
| NOCARDIA PCR [IF15] | | 6350 |
| AUTOIMMUNE LIVER DISEASE PROFILE 1 [MP3] | | 7050 |
| LIVER BIOPSY SECOND OPINION | | 5200 |
| NOCARDIA SPECIES IDENTIFICATION AND SENSITIVITY[HH15] | | 4500 |
| BONE MARROW - FLOW CYTOMETRY [UP2] | | 12600 |
| BONE MARROW KARYOTYPING [UP7] | | 3780 |
| BONE MARROW RT-PCR ALL PANEL [UP7] | | 12600 |
| CIRCULATING TUMOR DNA (CTDNA) BY NGS MGM2718[MG25] | | 78800 |
| Oncoprecise 52 Gene NGS panel) [LI30] | | 50400 |
| GALACTOCEMIA [NG5] | | 300 |
| FIT (FECAL IMMUNOICHEMICAL TEST) [MP2] | | 5300 |
| ENTAMOEBA HISTOLYTICA PCR -PUS [IF3] | | 6300 |
| ALLERGY SCREENING PANEL-TOTAL IGE ANTIBODIES WITH PHADIATOP(A0399) [MP2] | | 1900 |
| ALLERGY SCREENING ADULT PANEL-2[A0635][MP3 | | 6500 |
| Magnesium Research OBG | | 200 |
| MSI BY PCR ON PARAFFIN BLOCK | | 15100 |
| I-STAT CHEM8+[1] | | 1800 |
| INFLUENZA VIRAL PANEL[1] | | 7600 |
| ORION FOCUS -CLINICAL EXOME T4595 [ND26] | | 21800 |
| CT-NG(Chlamydia Trachomatis & Neisseria Gonorrhoae) by RT -PCR, Urine-C0373[MP5} | | 5600 |
| UPPER RESPIRATORY MULTIPLEX PANEL [If2] | | 12600 |
| BRUCELLA ANTIBODIES [MP2] | | 1100 |
| CANCER TRACK - LIQUID BIOPSY OF SOLID ORGAN TUMORS-DGC058[DL13] | | 54200 |
| Urine Anion Gap(UAG) | | 1100 |
| EPSTEIN-BARR VIRUS (EBV) DNA RT-PCR (VIRAL LOAD)(E0051) [MP5] | | 8400 |
| DUAL MARKER + PLGF | | 5000 |
| SINGLE ANTIGEN BEAD CLASS 1 BY LUMINEX (H0308 )[MP2] | | 25600 |
| SINGLE ANTIGEN BEAD CLASS 2 BY LUMINEX (H0309)[MP2] | | 25600 |
| KINSHIP ANALYSIS FOR SOLID ORGAN TRANSPLANT [MP8] | | 11000 |
| PANEL REACTIVE ANTIBODY CLASS 2 [MP2] | | 11900 |
| PANEL REACTIVE ANTIBODY CLASS 1 [MP2] | | 11900 |
| PANEL REACTIVE ANTIBODY CLASS 1 AND CLASS 2 [MP2] | | 6600 |
| HLA TYPING A,B,C,DR,DQ Loci(CLASS 1 and CLASS 2) SSOP LUMINEX(H0216)[MP2] | | 22200 |
| HLA High Resolution Typing (A, B, C, DR, DQ, DP) - Solid organ Transplant Gene Panel by NGS-H0849[MP | | 15800 |
| SOMATIC COMPREHENSIVE GENETIC PANEL [DL10] | | 115500 |
| BARTONELLOSIS IGG ANTIBODY BI002 [MP28] | | 13800 |
| AIH EXTENDED PROFILE (MP4] | | 9500 |
| CDT test (Carbohydrate Deficient Transferrin) -serum[MP5] | | 5300 |
| ANTI INFLIXIMAB ANTIBODIES[A0628][MP20] | | 17400 |
| MGMT METHYLATION[LI18] | | 11300 |
| WHOLE GENOME SEQUENCING(MEAN 30X) MGM275 [MG21] | | 140700 |
| FOOD INTOLERANCE (VEGETARIAN PANEL), SERUM(F0112)[MP5] | | 12100 |
| CANCER DETECTION PROFILE – FEMALE(C0021)[MP7] | | 11000 |
| CANCER SCREEN PROFILE – MALE(C0022)[MP2] | | 8500 |
| ADEQUACY OF TISSUE ( FROZEN SECTION)[1] | | 2100 |
| MUMPS PCR -CSF-PLASMA [IF2] | | 6800 |
| ALKAPTONURIA(HGD) GENE ANALYSIS(MGM509)[MG20] | | 20200 |
| CANASSIST BREAST [ZL12] | | 85100 |
| BARTONELLA HENSELAE RT-PCR[IF7] | | 8800 |
| FACTORS & COAGULATION STUDIES[NIIH5] | | 3200 |
| BONE & JOINT INFECTION PANEL BY FILMARRAY (BIOFIRE), SYNOVIAL FLUID (B8596)[MP2] | | 30200 |
| HOME CARE VISIT CHARGES 10+[1] | | 500 |
| NGS FLUID INFECTION TESTING[HS2} | | 9200 |
| CSF CELL BLOCK REPORTING[SL4] | | 1600 |
| LIQUID BIOPSY -NGS PANEL -ONCOPRECISE[LI21] | | 24600 |
| HISTOPATH EXAMINATION SECOND OPINION[MP3] | | 3300 |
| MPO (Myeloperoxidase) Stain, EDTA Blood (M0065)(MP5) | | 1300 |
| POST TRANSPLANT VIRAL SCREENING MULTIPLEX PCR [IF2] | | 12600 |
| CMV (CYTOMEGALOVIRUS) DNA QUANTITATIVE (VIRAL LOAD) BY RT-PCR, URINE(C0371)[MP4] | | 8100 |
| ANCA(Anti neutrophil cytoplasmic antibody)(A0445)[MP2] | | 2600 |
| FISH CEP XY(CHIMERISM)(F0034)[UP15] | | 3700 |
| MYD 88(Block&CSF)MUTATION ANALYSIS[SL15] | | 12600 |
| BCR ABL FISH [UP4] | | 5300 |
| HERPES SIMPLEX VIRUS 1-2 DNA RT-PCR[MP4] | | 5300 |
| EWSR1-FLI1 TRANSLOCATION (11-22) [LI5] | | 10100 |
| PGT- A + PGT-M(FOR 3 EMBRYO-1VARIENT) | | 100800 |
| PGT- A + PGT-M(FOR 4 EMBRYO-1 VARIENT)[LI38] | | 130200 |
| PGT- A + PGT-M(FOR 5 EMBRYO-1 VARIENT)[LI38] | | 157500 |
| ATDI- Comprehensive CDC Crossmatch[CCDC][2] | | 8500 |
| ATDI- Allo Flowcytometry Crossmatch[AFCXM][2] | | 9300 |
| ATDI- HLA Virtual cross match and/ OR composite Histocompatibility report [VXM][2] | | 5500 |
| ATDI- HLA A,B,C, DR, DP, DQ, DR, DRB345 [SS03][2] | | 53600 |
| 24 HOUR URINE NOR METANEPHRINE (N0037)[MP9] | | 2700 |
| MICROBIOLOGY SPECIMEN PROCEDURE CHARGES [1] | | 1100 |
| JAK2 V617F MUTATION REFLEX PROFILE,EDTA BLOOD (J0016)[MP14] | | 13900 |
| Germline HRR[SL16] | | 22100 |
| Guardant 360 - Liquid 740 Gene[ZY25] | | 289800 |
| Guardant 360 – Tissue V2[ZY25] | | 280400 |
| ANDROGEN PROFILE (A0446) | | 4900 |
| VIRAL SCREENING MULTIPLEX(PC168)[IF2] | | 8400 |
| SINGLE GENE MUTATIONS[LI25] | | 13100 |
| IPT - ALL MRD (I0061)[UP15] | | 13900 |
| ONCOSET SOLID NGS PANEL[NB30] | | 23900 |
| Folate Receptor Autoantibody Test (FRAT) ,Serum(F8281)[MP65] | | 88200 |
| MENINGOENCEPHALITIS MULTIPLEX(PC126)[IF2] | | 34000 |
| MALARIA DNA DETECTION BY PCR (M0007)[MP4] | | 3900 |
| CMV DRUG RESISTANCE[UP11] | | 12600 |
| NEUTROPENIC PYREXIS MULTIPLEX [IF2] | | 40300 |
| MPN Panel1(JAK2(12-15),MPL,CALR(P00018)(CD12) | | 17600 |
| OncoCEPT-Liquid Comprehensive(T1109)[SL13] | | 44100 |
| Small Endometritis Panel [GX10] | | 9500 |
| Comprehensive Endometritis Panel[GX13] | | 25200 |
| BCID BLOOD PANEL BY FILMARRAY -BIOFIRE- BLOOD CULTURE [[MP2] | | 22400 |
| AEROBIC CULTURE and SENSITIVITY For Upper Respiratory-NASO SWAB,THROAT SWAB,SPUTUM,NASOTRACHEAL[3] | | 2100 |
| CIDP (Nodopathy/Paranodopathy)[ZLS12] | | 59900 |
| Autoimmune Myelopathy Evaluation Panel in CSF [ZLS7] | | 42800 |
| Autoimmune Myelopathy Evaluation Panel in Serum[ZLS7] | | 50400 |
| STIFF PERSON SYMDROME[ZLS8] | | 41600 |
| Hemochromatosis (HFE) (C282Y, H63D) Gene Mutation Detection, EDTA Blood[H0002][MP10] | | 11300 |
| Drug Allergen - Gentamycin, Serum(A8619)[MP6] | | 2100 |
| MLH1 Promoter Methylation Assay[LI15] | | 12000 |
| YEAST INDENTIFICATION FOR MALDI-TOF [HH3] | | 1100 |
| EMA BINDING TESTS FOR HEREDITORY SPHEROCYTOSIS E0016[UP7] | | 5300 |
| Homovanillic Acid - Quantitative, Urine 24 Hrs(H0314)[MP14] | | 8600 |
| Target Indiegene SoLiq[4BC16] | | 315000 |
| Allergy Panel - CRD (Component Testing)(A0680)[MP4] | | 26500 |
| VZV VARICELLA ZOSTER VIRUS DNA DETECTION BY PCR SWAB[MP5](V0027) | | 4260 |
| Target Indiegene + Target First Free Liquid(4BC18) | | 135000 |
| POLE mutation analysis by Digital Droplet PCR(P8662)[MP15] | | 12500 |
| MMR IHC + MSI PCR(M0160)[MP20] | | 16900 |
| CD-138 [GX13] | | 7000 |
| D8479-(Alzheimer’s Disease Screening Profile : Plasma p Tau 217 /ß Amyloid 1-42 ratio[MP10] | | 15525 |
| APOE Genotyping, EDTA Blood(A0618)[MP14] | | 28952 |
| Alexander disease (GFAP) gene analysis(NA3900)[MP22] | | 18500 |
| FLUID CYTOLOGY WITH SPECIAL STAIN [HH2] | | 3500 |
| Fluid Cytology with Cell Block[NB5] | | 3500 |
| Injection Intramuscular | | 0 |
| Intravenous therapy | | 0 |
| Blood pressure | | 0 |
| HGT | | 0 |
| ECG | | 0 |
| Nebulization | | 0 |
| Major Dressing | | 0 |
| Minor Dressing | | 0 |
| Bladder wash | | 0 |
| Urinary catheterization | | 0 |
| Urinary catheterization removal | | 0 |
| Enema | | 0 |
| Stoma care | | 0 |
| Ryles tube removal | | 0 |
| Injection Subcutaneous | | 0 |
| Injection Intravenous | | 0 |
| PAIN MANAGEMENT | | 0 |
| ELECTROTHERAPY | | 0 |
| POST JOINT REPLACEMENT THERAPY | | 0 |
| POST FRACTURE REHABILITATION | | 0 |
| POST ARTHROSCOPY REHABILITATION | | 0 |
| SPINE REHABILITATION | | 0 |
| NEURO REHAB | | 0 |
| POST NEURO SURGERY REHAB | | 0 |
| CHEST PHYSIOTHERAPY | | 0 |
| CARDIOPULMONARY REHABILITATION | | 0 |
| ANTE- AND POST NATAL EXERCISES | | 0 |
| GERIATRIC REHAB | | 0 |
| GENERAL FITNESS EXERCISES AND STRETCHES | | 0 |
| GENERAL PHYSIOTHERAPY | | 0 |